A study on correlation of various anthropometric measures and serum homocysteine level with the severity of coronary artery disease in young patients undergoing coronary angiography. by Suresh, G
A Dissertation on 
 
A STUDY ON CORRELATION OF VARIOUS ANTHROPOMETRIC MEASURES AND SERUM 
HOMOCYSTEINE LEVEL WITH THE SEVERITY OF CORONARY ARTERY DISEASE IN YOUNG 
PATIENTS UNDERGOING CORONARY ANGIOGRAPHY  
 
Submitted to 
 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI – 600032. 
 
In partial fulfillment of the Regulations 
For the Award of the Degree of 
 
     M.D. BRANCH - I 
 
 GENERAL MEDICINE 
 
 
 
 
 
 
 
 
DEPARTMENT OF GENERAL MEDICINE 
STANLEY MEDICAL COLLEGE 
CHENNAI – 600 001. 
APRIL 2015 
 
CERTIFICATE BY INSTITUTION 
 
 
 
 
                This is to certify that Dr. G.SURESH, Post - Graduate Student (MAY 
2012 TO APRIL 2015) in the Department of General Medicine STANLEY 
MEDICAL COLLEGE, Chennai- 600 001, has done this dissertation on “A STUDY 
ON CORRELATION OF VARIOUS ANTHROPOMETRIC MEASURES AND SERUM 
HOMOCYSTEINE LEVEL WITH THE SEVERITY OF CORONARY ARTERY DISEASE IN YOUNG 
PATIENTS UNDERGOING CORONARY ANGIOGRAPHY”  under our guidance and 
supervision in partial fulfillment of the regulations laid down by the Tamil Nadu 
Dr.M.G.R. Medical University,Chennai for M.D (General Medicine), Degree 
Examination to be held in April 2015. 
 
 
 
 
Dr.R.JAYANTHI M.D.             Dr.AL.MEENAKSHI SUNDARAM,M.D.,D.A. 
Professor & HOD Dean 
Department of Medicine Govt. Stanley College & Hospital 
Govt. Stanley Medical Chennai 
College & Hospital 
Chennai 600001 
 CERTIFICATE BY GUIDE 
 
 
 
                This is to certify that Dr. G.SURESH, Post - Graduate Student (MAY 
2012 TO APRIL 2015) in the Department of General Medicine STANLEY 
MEDICAL COLLEGE, Chennai- 600 001, has done this dissertation on “A STUDY 
ON CORRELATION OF VARIOUS ANTHROPOMETRIC MEASURES AND SERUM 
HOMOCYSTEINE LEVEL WITH THE SEVERITY OF CORONARY ARTERY DISEASE IN YOUNG 
PATIENTS UNDERGOING CORONARY ANGIOGRAPHY”  under our guidance and 
supervision in partial fulfillment of the regulations laid down by the Tamil Nadu 
Dr.M.G.R. Medical University,Chennai for M.D (General Medicine), Degree 
Examination to be held in April 2015. 
 
 
 
 
PROF. DR. K. KANNAN, M.D, D.M. DR. K. TAMILSELVAN, M.D, D.M. 
Professor and HOD Asst. Professor                                   
Dept. of Cardiology                           Dept. of Cardiology                           
Stanley Medical College. Stanley Medical College. 
 
DECLARATION 
I  Dr. G.SURESH declare that I carried out  this  work  on  
“A STUDY ON CORRELATION OF VARIOUS ANTHROPOMETRIC 
MEASURES AND SERUM HOMOCYSTEINE LEVEL WITH THE SEVERITY 
OF CORONARY ARTERY DISEASE IN YOUNG PATIENTS UNDERGOING 
CORONARY ANGIOGRAPHY”at the CARDIOLOGY HUTTON WARD of 
Government Stanley Hospital during the period NOVEMBER 2013 to SEPTEMBER 
2014. I also declare that this bonafide work or a part of this work was not submitted by 
me or any other for any award, degree, or diploma to any other university, board either in 
India or abroad. 
This is submitted to The Tamil Nadu Dr.M.G.R. Medical University, Chennai in 
partial fulfilment of the rules and regulation for the M. D. Degree examination in General 
Medicine. 
 
 
 
 
Dr.G.SURESH 
ACKNOWLEDGEMENT 
At the outset I thank our Dean Dr.AL.MEENAKSHI SUNDARAM, 
M.D.,D.A. , for permitting me to carry out this study in our hospital. 
I express my profound thanks to my esteemed Professor and Teacher 
Dr.P.VIJAYARAGAVAN, M.D., Professor and Former HOD of Medicine, 
Stanley Medical College Hospital, for encouraging and extending invaluable 
guidance to perform and complete this dissertation. 
I immensely thank DR.K.KANNAN, M.D.,D.M Professor and HOD of 
Cardiology, for permitting me to do my study in Stanley cardiology department 
and for his constant suggestions and support. 
I thank DR.K.TAMILSELVAN, M.D.,D.M Assistant Professor of 
Cardiology for his guidance and constant encouragement throughout the study. 
 
I extend my sincere thanks to my unit chief Dr.G.VASUMATHI, M.D., 
Professor  Of Medicine  for her constant encouragement. 
 
I wish to thank Dr.A.RAMALINGAM,M.D., and Dr.S.M.SUJATHA,M.D., 
Assistant Professors of my unit,Department of Medicine,Stanley medical college 
Hospital for their valuable suggestions, encouragement and advice. 
I sincerely thank the members of Institutional Ethical Committee, Stanley 
Medical College for approving my dissertation topic. 
I thank all my Colleagues, House Surgeons, and Staff nurses and other para 
medical workers for their support. 
Last but not the least; I sincerely thank all those patients who participated in 
this study, for their co-operation. 
 
 
 
 
 
 
 
 
TABLE OFCONTENTS 
TITLE                    PAGE NO: 
 
I. INTRODUCTION 01 
 
II. REVIEW OF LITERATURE 02 
 
III. AIM AND OBJECTIVES 69 
 
IV. MATERIALS AND METHODS 70 
 
V. RESULTS AND DISCUSSION  72 
 
VI. CONCLUSION 114 
 
VII. ANNEXURES 116 
 
 BIBLIOGRAPHY 
 PROFORMA 
 CONSENT FORM 
 ETHICAL COMMITTEE APPROVAL LETTER 
 MASTER CHART 
 
ABBREVIATIONS 
 
 
CAD – CORONARY ARTERY DISEASE 
CAG – CORONARY ANGIOGRAM 
LAD – LEFT ANTERIOR DESCENDING 
LCX – LEFT CIRCUMFLEX 
RCA – RIGHT CORONARY ARTERY 
HT – HEIGHT 
WT – WEIGHT 
BMI – BODY MASS INDEX 
SAD – SAGITTAL ABDOMINAL DIAMETER 
TSFT – TRICEPS SKIN FOLD THICKNESS 
WHR – WAIST HIP RATIO 
LDL – LOW DENSITY LIPOPROTEIN 
HDL – HIGH DENSITY LIPOPROTEIN 
VLDL – VERY LOW DENSITY LIPOPROTEIN 
TGL – TRIGLYCERIDES 
HT – HYPERTENSION 
DM – DIABETES 
CKD – CHRONIC KIDNEY DISEASE 
CVA – CEREBROVASCULAR ACCIDENT 
ECG ELECTROCARDIOGRAPHY 
ECHO – ECHOCARDIOGRAPHY 
CT- COMPUTED TOMOGRAPHY 
AGE - ADVANCED GLYCATION END PRODUCTS 
BP – BLOOD PRESSURE 
COA – COENZYME A 
ACC – AMERICAN COLLEGE OF CARDIOLOGY 
AHA – AMERICAN HEART ASSOCIATION 
ABSTRACT : 
AIMS AND OBJECTIVES 
1. TO STUDY CORRELATION OF VARIOUS ANTHROPOMETRIC MEASURES AND 
SERUM HOMOCYSTEINE LEVEL WITH THE SEVERITY OF CORONARY 
ARTERY DISEASE. 
2. TO IDENTIFY STRONG ANTHROPOMETRIC PARAMETER CORRELATING 
WITH THE SEVERITY OF CORONARY ARTERY DISEASE USING CAG. 
KEY WORDS:Anthropometry, Sagittal abdominal diameter, Triceps skin fold thickness,  
Serum homocysteine, Modified gensini scoring,  Coronary angiography  
 
MATERIALS AND METHODS 
PLACE OF STUDY: 
 
HUTTON WARD, DEPARTMENT OFCARDIOLOGY,   STANELY MEDICAL COLLEGE 
AND HOSPITAL, CHENNAI. 
DURATION: NOV 2013 TO SEP 2014 
 
STUDY DESIGN 
 
PROSPECTIVE AND OBSERVATIONAL STUDY  
 
SOURCE OF DATA: 
 
PATIENTS WITH HISTORY OF CHEST PAIN WHO FULFILL THE INCLUSION AND 
EXCLUSION CRITERIA, GETTING ADMITTED AT CARDIOLOGY HUTTON WARD,  
STANLEY MEDICAL COLLEGE, CHENNAI DURING THE PERIOD OF NOV 2013 TO 
SEPTEMBER 2014 AND PLANNED FOR CORONARY ANGIOGRAM. 
SAMPLE SIZE:  75 
INCLUSION CRITERIA:  
1. ALL PATIENTS UNDER 50YRS OF AGE , ADMITTED IN CARDIOLOGY 
DEPARTMENT HUTTON WARD, STANLEY MEDICAL COLLEGE FOR 
UNDERGOING CORONARY ANGIOGRAM 
 
 EXCLUSION CRITERIA: 
1. PATIENTS KNOWN TO HAVE RHEUMATIC HEART DISEASE, ISCHEMIC 
DCMP. 
2. PATIENTS WHO ARE ABOVE THE AGE OF 50 YRS. 
3. PATIENTS WHO ARE CHRONIC ALCOHOLICS. 
4. PATIENTS WITH CHRONIC KIDNEY DISEASE. 
5. PATIENTS WITH ASCITES AND OTHER INTRABDOMINAL PATHOLOGY. 
6. PATIENTS WITH HB < 11GM% 
METHODOLOGY 
Patients admitted for angiography between November 2013 to September 2014 will be 
included in the study. 
DATA COLLECTED USING A PROFOMA MEETING THE OBJECTIVES OF THE 
STUDY. 
 DETAILED HISTORY, PHYSICAL EXAMINATION AND NECESSARY 
INVESTIGATIONS WILL BE UNDERTAKEN. 
They are subjected for anthropometry measurements including height, weight, BMI, hip 
and waist circumference, WHR, sagittal abdominal diameter, triceps skin fold thickness 
and SAD/TSFT ratio measured. Also their serum homocysteine level, glycemic status, 
Presence or absence of hypertension and diabetes, smoking and alcohol intake with 
duration, life style & physical activity, frequency of chest pain, ECG findings and echo 
status will be noted prior to angiogram. 
Post angiogram evaluation of severity of coronary artery stenosis made my Modified Gensini 
Score. 
THE PURPOSE OF THE STUDY WILL BE EXPLAINED TO THE PATIENT AND 
INFORMED CONSENT OBTAINED 
 
 
CONCLUSION 
In my study using 75 patients under 50 years, I am able to come to a conclusion of some 
anthropometric variables better correlating with the severity of coronary stenosis and some not 
showing much correlation as listed below 
1) Increased Waist-hip ratio, sagittal abdominal diameter, triceps skin fold thickness and 
SAD/TSFT ratio has got better correlation with the severity of coronary artery disease, 
with SAD/TSFT and WHR has got maximum significance of all anthropometric 
measurements. 
2) Increased BMI poorly correlating with the severity of CAD as shown by p value more 
than 0.05. 
3) Increased homocysteine level better correlates with the severity of coronary artery 
disease. 
4) Increased LDL cholesterol value had good correlation with CAD severity butdecreased 
HDL cholesterol not correlating much with coronaryartery disease. 
5) Duration of smoking but not mere smoking history better correlates with the severity of 
coronaryartery disease.Smoking is found to be an independent high risk factor even in 
patients with low BMI, low waist or hip circumference and low WHR or SAD/TSFT 
ratio. 
6) Presence of hypertension and duration of diabetes got positive correlation on coronary 
artery disease severity. 
7) Left ventricular ejection fraction (LVEF) also correlates with the severity of coronary 
artery disease with an inverse relation between them. 
8) Modified gensini score – higher the modified gensini score, severe is the coronary artery 
disease. 
9) It appears that the old concept of BMI being considered as major risk factor in the past 
will not apply nowadays as an important determinant for CAD risk assessment, as it is 
shown in our study and in many major studies to be statistically less significant and it’s 
better to give importance to central Vs peripheral obesity ratio methods to assess future 
risk of CAD. 
10) We feel great emphasis should be given on cessation of smoking compared to control of 
obesity as it’s a major atherosclerotic risk factor even in thin individuals and those 
patients are prone for CAD at very young age. 
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INTRODUCTION 
In recent days, humanity is constantly facing an increase in incidence of 
coronary artery disease. There are various determinants responsible for this 
major burden of mankind. Some risk factors can be modified and some 
cannot be modified. Among those modifiable risk factors like smoking, 
excess alcohol intake, abnormal dietary patterns, lack of physical activity, 
obesity and stress. 
Various anthropometric measurements have been studied over many years 
to act as predictor and risk factor for future development of metabolic 
syndromes and coronary artery stenosis. Central obesity is considered as 
major risk. 
Serum homocysteine has also been found in many studies to have impact on 
coronary artery disease severity. 
Our aim is to study impact of various anthropometric measurements and 
serum homocysteine level and their correlation with coronary artery disease. 
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REVIEW OF LITERATURE 
 
Coronary artery disease is basically a disease affecting those blood vessels 
that supply blood to heart. Atherosclerosis of coronary vessels is the 
forerunner for formation of coronary artery disease. It became significant 
when the narrowing of coronary vessels exceeds 50 % in any of coronary 
vessels. Basically there are 3 major coronary vessels and more than 8 minor 
branches of coronary arteries. 
Myocardial ischemia or infarct patients presents with any of the following 
symptoms including typical retrosternal chest pain which is compressive or 
unexplainable vague pain, dyspnea and angina equivalents like sweating, 
back pain, palpitation and vomiting.  
Hereby I am studying the correlation of various anthropometric measures 
and serum homocysteine level in patients under fifty years comparing with 
the coronary artery disease severity using modified gensini scoring method. 
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There are various risk factors attributed to the formation of plaques in the 
coronary vessels. Those include smoking, lack of exercise, 
obesity,diabetes,hypertension,hyperhomocysteinemia and so on. 
Development of coronary artery disease can be diagnosed by invasive and 
noninvasive methods. 
Invasive methods include those of CT angiogram using cardiac catheters 
and intravascular ultrasonography. 
Noninvasive methods include simple ECG,echocardiography,treadmill 
test&cardiac MRI angiography. 
ECG acts as the basic first line investigation for those presenting for the 
first time with cardiac chest pain. It will provide information on 
ischemia,injury or infarct of a particular cardiac wall involvement and also 
the concomitant presence of bundle branch blocks and nodal involvement. 
The problem with ECG is it will not detect all cases of ischemia as it has got 
low sensitivity and there are many bias possible by means of normal 
variants and by coincidental electrolyte disturbances in same patient. 
 
 4 
 
Exercise testing 
It is a cardiovascular stress test that uses treadmill bicycle exercise with 
ECG and blood pressure monitoring. Testing is a diagnostic procedure in 
which cardiovascular stress induced by pharmacologic agents is 
demonstrated in patients with decreased functional capacity or in patients 
who cannot exercise. 
Both of which helps to identify those at risk of stress induced coronary 
vasospasm and helps to warn them to avoid strenuous exercise and activities 
and need for coronary angiography. 
 
Echocardiography is a gold standard test to identify hypokinesia and 
akinesia of a particular portions of myocardium that could be basal, mid or 
apical portion of the left ventricular anterior wall, inferior wall, posterior 
wall or lateral wall. It also helps to identify the LV ejection fraction. 
It can also help to exclude other causes of cardiac pain other than frank 
coronary vascular stenosis including septal defects, aortic and other valve 
involvement like stenosis or valve prolapse. 
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Obesity and type -2 diabetes are the major risk factors attributed in coronary 
stenosis. Population most affected by these are men in south East Asia 
particularly India and Middle East. 
There are also genetic predilection to the development of atherosclerosis.  
 
METABOLIC SYNDROME 
The metabolic syndrome is closely related with development of diabetes, 
insulin resistance and high chances of development of CAD. 
Its diagnosis comprises following components 
1) Waist circumference >90 in Indian men and >80 in Indian women with  
2) Two or more of the following   
a. Fasting triglycerides > 150 mg% , HDL<40mg% for men and 
<50mg% for women on diagnosis 
b.  BP >130 mm of hg systolic , > 85mmm of hg diastolic on 
diagnosis  
c. Fasting plasma glucose >100mg% or known diabetic. 
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The primary pathogenesis for metabolic syndrome being increased 
insulin resistance. High free fatty acids in serum leads to substrate 
availability and thus produces insulin resistance by down streaming 
signals. Excess fatty acids impairs insulin mediated glucose uptake and 
accumulation of triglycerides in muscles and also increased glucose and 
TGL production in liver increased. 
 
Various anthropometric measurements 
Height – measured with standard ruler with patient in standing position with 
abdominal relaxation and with feet’s together and whole body attached 
closely to the wall. 
Weight -measured with weighing machine with patient looking forward, 
and in straight position without leaning forward. 
BMI - body mass index is the ratio of weight in kilograms to the height in 
meter squares. 
 
 7 
 
For Indian population, BMI more than 23 is considered overweight and 
more than 37.5 is considered morbid obesity. 
 
Fat distribution in human body can in form of visceral or subcutaneous fat 
deposits. 
Among those two , visceral fat deposits poses major health risk as those 
fatty acids derived from visceral fat will be delivered to liver compared to 
subcutaneous fat which will be delivered to peripheral circulation mostly. It 
is also established that increased visceral fat and waist circumference is 
directly related to the future development of CAD.  
Even in the subcutaneous fat distribution, central abdominal fat is more 
dangerous than peripheral body subcutaneous fat. Even peripheral fat 
considered to have beneficial effect. 
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Visceral fat is more in cases of Asian / Indians. Waist circumference, waist-
hip ratio, sagittal abdominal circumference (SAD), SAD/triceps skin fold 
thickness are among parameters which determines central obesity. 
Waist circumference is the measure of circumference measured at the level 
of midway between iliac crest and lower rib margin. For Indian population, 
those with WC > 90 cm in men and > 80 cm in women is considered as 
abnormally high waist circumference and are at high risk for development 
of insulin resistance, diabetes and coronary artery stenosis. 
Hip circumference is being measured at the level of greater trochanter of 
femur, this measurement is being used for comparison with waist 
circumference, to measure waist/hip ratio. 
Waist-hip ratio (WHR) is the measure of waist circumference divided by 
hip circumference. This ratio projects the central obesity. The value must 
not exceed more than 0.9 in men and 0.8 in women.  
 
Sagittal abdominal diameter (SAG) is an important reflection of visceral 
obesity.- 
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SAD was measured as the height of the abdomen in the supine position from 
the table measured at the waist after gentle expiration, by use of portable 
sliding-beam caliper. 
The upper arm of the caliper was at the upper abdominal surface at iliac 
crest level, which approximates the level of the L4-L5 interspace. 
 
For a person within normal limits of BMI, sagittal abdominal diameter 
should be within 25 cms. SAD above 30 correlated with high incidence of 
diabetes, metabolic syndrome, hypertension and coronary artery disease. 
 
Triceps skin fold thickness is a measure of peripheral fat mass. It can be 
measured by pinching the vertical skin fold over mid-triceps region 
pinching away from muscle midway between acromial process and 
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olecranon process and measuring the thickness using vernier caliber or other 
instruments. 
 
 
Normal adult triceps skin fold thickness 
Male - 11-12.5 mm 
Female – 15-16.5 mm 
Boys at the age of 2 years have a median triceps skin fold of 10 mm after 
which it decreases gradually and by the age of eight years, reaches its lowest 
value of 8mm. After that it shows gradual increase, so that by age of twelve 
years, reaches a peak of 10 mm. 
In case of females, stable value between 2 to 8 years, with average of 
sixteen millimeter by 15 years. By adulthood have normally 17 to 22 mm. 
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By comparing the central obesity factors with the peripheral fat distribution, 
we are able to bring a better predictor of future dyslipidemia, diabetes and 
CAD occurrence. 
Often the peripheral fat distribution is safe than that of central fat 
distribution as shown in many studies like increased ‘waist-hip ratio’ and 
‘waist-thigh ratio’ has got worse outcome as evident in coronary angiogram. 
Waist-hip ratio is one among such predictor. Many studies have shown a 
good correlation between ‘waist hip ratio’ with the incidence of coronary 
artery disease in the form of angina(either stable or unstable), myocardial 
ischemia and infarction. 
Sagittal abdominal diameter / triceps skin fold thickness (SAD/TSFT) 
Another such good variable to comparing central with peripheral adiposity 
is the sagittal abdominal diameter / triceps skin fold thickness. This has been 
recently concentrated and found as better anthropometric variable to predict 
CAD and correlates with the severity and extend of coronary stenosis as 
measured by using modified gensini scoring system. 
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Anatomy of coronary arteries 
Coronary artery are those vessels that around the heart arising from the 
coronary sinus at aortic root level. There are right coronary artery and left 
main coronary arteries arising respectively from right and left aortic sinuses. 
Left main coronary artery first gives of left circumflex coronary artery 
that runs in left anterior atrioventricular groove and then continues down 
anteriorly as left anterior descending artery in the anterior interventricular 
groove. 
Right coronary artery has its own course starting from 
anterioratrioventricular groove and runs to posterior atrioventricular groove 
and descends usually in posterior interventriculargroove. 
Dominant artery is the one coronary artery that give rise to posterior 
interventricular branch and supplies the posterior part of the ventricular 
septum and sometimes posterolateral wall of the left ventricle. 
The dominant artery is usually the right coronary and less commonly 
from left circumflex artery, which after passing posterior atrioventricular 
groove runs down in posterior interventricular groove. 
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 Anastomoses between right and left coronary arteries are more during fetal 
life and the same is much reduced by the end of the first year of life. 
Anastomoses provides collateral circulation when either of the artery is 
subjected to stenosis. They become prominent in scenarios of hypoxia and 
CAD. Collateral circulation also given by tiny branches from mediastinal 
and bronchial vessels. 
The artery to the Sino atrial node is usually from the anterior circumflex 
segment and less common from the circummarginal branch. 
Stenosis of this branch is crucial as it causes SA node to dysfunction and 
that results in an events like sick sinus syndrome with very low heart rate as 
other conduction system below the level of SA node will take over the 
intrinsic cardiac impulse generator and that have an intrinsic rate less than 
that of SA node. 
Those subsidiary pacemakers includes conduction fibers namely Bachmann, 
wenkebach and  thorel pathways that connects SA node with AV node, 
atrial musculature itself, AV node, bundle of his, right and left bundle 
branch and left anterior or posterior fascicular fibers and  ventricular 
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myocytes themselves. Hence bradycardia sets in if nodal arterial branch got 
thrombosed. 
There are several branches given off from these main coronary arteries. 
These include  
1) Form the left coronary artery– 
Left main coronary artery arising from the left aortic sinus and that gives 
rise to 
a) Left anterior descending branch which runs in anterior 
interventricular groove and end up after winding in posterior 
interventricular groove. 
b) Left circumflex coronary artery – which is also a main branch from 
left main coronary artery and that runs in anterior atrio-ventricular 
region and winds to end in posterior atrio-ventricular groove. 
c) Left obtuse marginal branch is usually a sub branching from left 
circumflex artery. 
d) Left diagonal branch arises from the left anterior descending artery. 
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e) Intermediate artery – found in around one third of patients arising 
between LAD and LCX and one runs along anterolateral aspect of the 
left ventricle. 
f) There can be more than one marginal branches in few people 
possible. 
2) Right coronary artery - arises from the right aortic sinus of aorta 
and  
a) Runs along the right atrioventricular groove and winds up from 
inferior portion and runs along the posterior interventricular grove 
to supply the myocardium adjacent to it. 
b) Right acute marginal branch arise when the right coronary 
artery winds in the inferior surface of the heart. 
c) A branch to the Sino atrial node. 
d) Several other minor anatomic variant branches can occur. 
 
 
 
 16 
 
Communication between the Left and Right Coronary Arteries 
1. The artery of the conus with left anterior descending artery. 
2. At the interventricular septum, with septal perforators of left 
anterior descending artery and posterior descending artery. 
3. At the apex of the heart, between left anterior descending and 
posterior descending artery. 
4. At the crux, between the left circumflex and posterior descending artery. 
 
Coronary microvasculature – it includes the microcapillary circulation 
which runs in the form of coronary capillaries that are parallel to the 
myocytes. 
 
Distribution of Blood supply of the heart 
Heart has got three important layers including epicardium, myocardium and 
endocardium. 
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The epicardium can be supplied by micro branches from epicardial vessels.  
The myocardial blood supplied is briefed here- 
Most of the left ventricular surface except near posterior interventricular 
septum is supplied by left anterior descending artery. 
Most of the right ventricle except near anterior interventricular septum is 
supplied by posterior descending artery. 
Both atria are supplied by branches form circumflex and right coronary 
artery. 
 
Coronary oxygen supply- 
Myocardium unlike other tissues the percentage 02 demand per gram of 
myocardium is very high compared to any other cells. 
It is dependent on pa02 content of blood & hemoglobin concentration. 
The main factors responsible for increased oxygen demands includes heart 
rate, systolic blood pressure and left ventricular contractility factor. 
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The coronaries are being filled during diastolic phase of the cardiac cycle 
and so when the heart rate increases (which shortens diastolic phase) 
coronary arterial filling decreases and myocardium suffers from 
hypoperfusion and undergoes ischemia and if the same status continues, it 
will end up in infarct. 
 
Coronary Collateral Circulation  
After total coronary occlusion, residual myocardium gets perfused through 
native coronary collateral channels that open when an intercoronary 
pressure gradient between origin and distal vessel drops. There is large 
individual variability in the function of coronary collaterals in patients with 
chronic stenosis. In those without coronary collaterals, coronary pressure 
distal to balloon angioplasty comes down to 10 mm Hg. In other patients, 
collaterals proliferate to the point where they are sufficient not only to 
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maintain normal resting perfusion but also to prevent stress-induced 
ischemia at submaximal cardiac workloads. Ischemia does not develop 
during PCI balloon occlusion when fractional flow reserve (based on 
coronary wedge pressure during occlusion minus venous pressure) is greater 
than 0.25. A large observational cross-sectional study has shown that 
patients with high distal coronary pressure attained through collaterals, 
fractional flow reserve > 0.25 have a lower CAD rate. 
 
The volume of residual coronary flow through collaterals or by subtotal 
coronary occlusion has got most influence on the actual time of irreversible 
injury in patients with chronic CAD. The relationship between infarct size 
and the area at risk of ischemia during a total occlusion is inversely related 
to collateral flow.so this gives us the importance of collateral vessel 
function in determining prognosis. When subendocardial collateral flow is 
more than approximately 30% of resting flow values, more than 1 hour of 
protection to the myocardial injury is for sure. More moderate 
subendocardial ischemia from a subtotal occlusion with flow reduction of 
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less than 50% from baseline can prevent for about 5 hours the irreversible 
injury of the myocardium. This explains the reason behind less 
symptomatology and absence of ECG finding in early stages without 
producing much of myocardial necrosis. It also explains the clinical 
observation that late coronary reperfusion with ongoing ischemia can 
salvage myocardium beyond the 6-hour time limit predicted from 
experimental models of infarction. 
 
Venous drainage of the heart:- 
The heart is drained from all around and final drainage is via coronary sinus 
that open up in the right atrium between the opening of the inferior vena 
cava and the right atrioventricular orifice. 
The tributaries of coronary sinus includes great, small and middle cardiac 
veins, the posterior vein of the left ventricle and the oblique vein of the left 
atrium 
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Great cardiac vein – drains left atrium and both ventricles. 
Small cardiac vein – drains Posterior part of right atrium and right 
ventricle. 
Middle cardiac vein – drains from cardiac apex. 
Posterior vein of left ventricle and oblique vein of left atrium drains the 
corresponding chambers. Anterior cardiac vein in anterior part of right 
ventricle and joins coronary sinus. Multiple perforating veins draining 
in individual chambers drains corresponding myocardium. 
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ATHEROSCLEROSIS 
Progressive accumulation of smooth muscle cells and lipids within the 
intima. 
Also starts with stretching of vessels causing smooth muscle cells to arrange 
in parallel rows and reactive deposits of fibrin and over the course of time, 
this causes vessels to became fibrotic due to fibrin generation by epithelial 
cells and became stiff not yielding to recoil and finally the cardiac output 
with its full systolic pressure will be transmitted directly to the offending 
organs and capillary damage sets in. 
 
Progression of atherosclerosis: 
 
Early stages: Proliferation of smooth muscle cells and accumulation of lipid. 
Later: macrophages, lymphocytes influx and connective tissue enlargement. 
Very late stage: thrombus with canals within the thrombus. 
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MORPHOLOGY: 
 
Initial lesion of atherosclerosis 
Fat streaks: can be found in young children as well as adults at any point. 
 
Intimal cell masses: found in branching places. 
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Characteristic lesion of atherosclerosis:  
Fibrous fatty plaque and fibrous cap which constitutes layer of fibrous 
connective tissue overlying the atheroma which has foam cells 
(A modified macrophages) and smooth muscle cells, and also fibroblasts. 
Atheroma: lipid rich necrotic center of the lesion. 
Risk factors include 
Hypertension 
 Dyslipidemia  
 Chronic smoking 
 Diabetes 
 Obesity with high BMI ,central obesity plays a major role 
 increasing age 
 male sex 
 physical inactivity 
 Stressful life patterns. 
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COMPLICATIONS OF ATHEROSCELOROSIS 
Those atheroma more prone for complications include those with a) 
calcification b) large thrombus c) neovascularization d) ulceration 
 
Most common complications depending on the organs involves 
1)  hypertension ,  
2) Chronic kidney disease 
3) Hypertensive retinopathy 
4) Chronic headache , 
5) Hypertensive small vessel ischemic changes in brain 
6) Stroke – either ischemic or hemorrhagic stroke 
7) Neuropathy 
8) Aneurysm formation 
9) Myocardial ischemia  or infarction 
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HYPERTENSION: 
A person is labelled as hypertensive if systolic bp > 140 mmhg and 
diastolic > 90 mmhg. 
Systolic cutoff is increased to 150 persons older than 50 years to start on 
antihypertensive medications. 
Hypertension can be  
a) Benign hypertension –with hyaline arteriosclerosis,without end organ 
damage and which remain asymptomatic or 
 b) Malignant hypertension – with end organ damage. Morphologically 
showing onion peel vessel damage and with fibrinoid necrosis. 
 
Basically hypertension can be  
1) Essential hypertension – without well known cause 
2) Secondary hypertension – due to any of the below causes 
Renovascular Ischemia: Renovascular stenosis or atherosclerosis of Renal 
Artery or arterioles which   result in renin release resulting in hypertension. 
Fibro muscular Dysplasia of Renal Artery is a congenital disorder, with 
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Progressive concentric thickening of the Renal Artery which occurs in 
young females. 
Cushing's syndrome – primary hypersecretion of cortisol. 
Conn's Syndrome - Primary hypersecretion of aldosterone. 
Pheochromocytoma- Adrenal medullary tumor. Norepinephrine is secreted 
in spurts, so patient will have wild paroxysmal elevations in blood pressure. 
 
DYSLIPIDEMIA  
 
Lipoproteins are those substances which contains mixed protein content and 
lipid substances. 
It can be 
Chylomicrons 
Low density lipoprotein 
Intermediate density lipoprotein 
Very Low density lipoprotein 
High density lipoprotein 
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Apoproteins are the proteins associated with lipoproteins 
There are numerous apoproteins. Apoproteins of importance are 
B48,B100, A1, A2, A4, C1, C2, C3 and E 
VARIOUS LIPOPROTEINS ARE  
CHYLOMICRONS – source being intestinal wall. Carries exogenous 
triglycerides to the liver. It’s around 90-1000 nm diameter. Density being 
<0.95 g/ml. main content being triglycerides. With Apo A1 A2 A4 B48 C1 
C2 C3 E 
CHYLOMICRON REMNANTS– formed after chylomicron acted 
upon by lipoprotein lipase with removal of most apoproteins with 
addesapoB48, E and cholesterol. 
VLDL - smaller than chylomicron, again from intestinal origin with 
triglycerides being major component, with Apo B100 C1 C2 C3 
IDL – derivative of VLDL after acted upon by lipase with removal of C1 
C2 C3 and Apo E add up. 
LDL – derived from VIDL and IDL after utilization in liver and removal of 
Apo E. contains loads of cholesterol. 
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HDL – derived from liver, intestine and from chylomicrons VLDL with 
Apo A1 A2 A4 C1 C2 C3 D and E. has more triglycerides and less 
cholesterol. 
Free / albumin bound fatty acids 
 
HDL cholesterol is named good cholesterol as it has got less cholesterol and 
has got reverse cholesterol transport bringing the cholesterol from periphery 
to liver for action by HMG CoA reductase and generation of free fatty acids 
for utilization and gluconeogenesis. Provides protection from coronary 
artery disease. 
 
LDL transports and delivers free cholesterol to the periphery and thus acts 
as bad lipoprotein as this assists in the atherogenesis process. Causative for 
CAD. 
VLDL – Provides endogenous triglycerides from liver to peripheral tissue. 
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Fatty acid metabolism 
Fatty acid synthesis 
This takes place in cytoplasm. Acetyl Co enzyme A is primer for synthesis 
of palmitic acid. Propionyl CoA is primer for synthesis of long chain fatty 
acids having odd number of carbon atoms. 
First and rate limiting step is the formation of acetyl CoA by acetyl CoA 
carboxylase by fixing CO2. 
Fatty acid elongation occurs both in mitochondria and microsomal system. 
O2 required for microsomal pathway. 
 
Formed fatty acids released free in circulation or in protein bound form. 
Fatty acids after activated by coenzyme A is being utilized in following 
biosynthesis 
a) Citric acid cycle via citrate synthase 
b) Cholesterol synthesis via HMG CoA synthase. 
c) Triglyceride biosynthesis. 
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Fatty acid oxidation occurs via Beta oxidation in either mitochondria or 
peroxisomes. 
Mitochondrial oxidation is for long and short chain fatty acids and result 
in ATP production. 
Peroxisomal oxidation is for very long chain fatty acids and is to shorten 
long FA’s and remove side chain of cholesterol. No ATP is produced 
here. 
 
 
OBESITY / DIABETES / HYPERTENSION INTERRELATION 
Obesity mainly the central fat mass acts as main contributor for insulin 
resistance and future diabetes development. 
Diabetes and hypertension are closely linked in such a way many factors 
acts as common for diabetes and hypertension. 
a) Platelet dysfunction 
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Platelet dysfunction occurs due to end glycation product’s impact 
on the platelet function and adherence properties which accounts 
for early atherogenesis and development of hypertension. 
 
 
b) Altered lipoprotein metabolism in diabetes accounting for 
hypertension can occur due to following abnormalities in 
lipoprotein metabolism and include 
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c) Endothelial dysfunction - various anatomic and functional 
abnormalities of the vascular endothelium are associated with both 
diabetes mellitus and hypertension. In patients with insulin 
resistance, endothelial lipoprotein lipase activity is decreased, so 
conversion of VLDL to LDL is reduced ant high chances of 
atherosclerosis is there as VLDL has got rich content of 
cholesterol which is injurious to endothelial cells. Hyperglycemia 
appears to contribute to endothelial dysfunction as 
well.Hyperglycemia promote protein kinase C in endothelial 
cells,which causes increased production of vasoconstrictor 
prostaglandins, endothelia and ACE. Increased PDGF and VGF 
appears, which enhances vasomotor constriction and vascular 
remodeling and growth. Also hyperglycemia alters endothelial cell 
matrix production, and basement membrane thickening. There is 
decreased endothelial nitric oxide production and effect. Increased 
expression of endothelial thrombomodulin. 
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d) Ill effects of advanced glycation end products includes those 
directly and some indirectly related to AGE( advanced glycation 
end products) 
Chronic hyperglycemia with advance glycation product at high 
concentrations  has a direct toxic effect on vascular endothelial 
cells which may lead to decreased endothelium mediated vascular 
relaxation, increased vasoconstriction, promotion of vascular 
smooth muscle cell hyperplasia, vascular remodeling, and 
atherosclerotic events. High glucose proven to induce the 
overexpression of fibronectin and collagen IV in cultured human 
vascular endothelial cell leading to endothelial cell dysfunction 
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and it causes the glomerular basement membrane to thicken and 
meningeal hyperplasia. 
 
Advanced glycation end products can do following detrimental 
effects as shown in below table 
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Homocysteine metabolism and its role in coronary 
artery disease: 
Homocysteine is a non-essential sulfur containing amminoacid, 
which has got its role in intermediate of two main pathways:  
 
1) Remethylation to methionine, which requires folate and 
vitamin B12 
2) Transsulfuration to cystathionine, which requires pyridoxal-5′-
phosphate.  
 
Both pathways are coordinated by S-adenosylmethionine, 
which is as an allosteric inhibitor of the 
methylenetetrahydrofolate reductase reaction and as an 
activator of cystathionine β-synthase. 
 Hyperhomocysteinemia is recently been studied extensively 
associated with increased risk of cardio-vascular disease. 
Severe hyperhomocysteinemia is due to rare genetic disorders 
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with defectsin enzymes namely cystathionine beta synthase, 
methylenetetrahydrofolate reductase, or in enzymes involved in 
methyl-B12 synthesis and homocysteine methylation 
 
Conversion of homocysteine to methionine requires methionine synthase 
enzyme with vitamin b12 as cofactor, which parallels the conversion of 
methylene tetrahydrofolate to tetrahydrofolate. 
Normal values 
 
MALE = 5.46-16.2 umol/lit 
FEMALE = 4.44-13.56 umol/lit 
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Any conditions which results in B12 deficiency like those of atrophic 
gastritis ,post gastrectomy, intrinsic factor deficiency , chronic alcoholics 
lead on to hyperhomocysteinemia and thus accelerated atherosclerosis 
including coronary arteries and early onset myocardial ischemia and infarct 
sets in even without other risk factors. 
Hyperhomocysteinemia leading to CVD risk is explained in many 
hypothetical methods but none proved. The proposed mechanisms by which 
hyperhomocysteinemia leads to cvd and overall atherogenesis includes 
direct endothelial injury , endothelial dysfunction , increase in intima medial 
thickness, increased activity of procoagulants  and immune dysfunction 
been proposed. 
The addition of methyl group to cytosine in genome is essential to decide 
gene product to be active or not. Defect in this process leads to inactive gene 
products and thus functional capacity of endothelium is lost along with its 
protective mechanisms. This is accounted for increase CVD risks and also 
stroke events in high incidence. 
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Vitamin B12 deficiency 
It can result in hyperhomocysteinemia. The reasons behind b12 deficiency 
could be due to  
A) Pernicious anemia – an autoimmune disease where autoantibodies are 
directed against one’s own bowel cells and there is destruction of 
those gastric mucosal cells that produces intrinsic factor. 
B) Short bowel syndrome – any operational or disease process which 
leads to small bowel loops especially the distal segments to shorten 
will leads to low b12 absorption from GIT. 
C) Chron’s disease – which makes small bowel mucosal dysfunction. 
D) Vegetarian diet – which is defective in b12 levels. 
E) Chronic alcoholics  
Endothelial dysfunction as a marker of future coronary artery disease 
Endothelium acts in many ways to influence the effect of the  
 
Endothelium function in a paracrine manner to adjust in case of shear stress 
situations like increase systolic pressure causing stretch of vascularity and 
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endothelium tend to get damaged and this being prevented by intrinsic 
capacity of vascular endothelial cells to secrete vasodilators like NO (nitric 
oxide) and prostanoids. 
NO is produced by potassium activated calcium channels which acts during 
periods of stress force, so that when potassium channel opens up calcium 
entry occurs and that causes activating of endothelial nitric oxide synthase – 
eNO’s. 
TheseeNO’s causes vasodilatation and thus accommodates the stress force 
and prevents the endothelial damage and thrombus formation. 
 
Nitric oxide is the vasodilator substance being internally synthesized in 
endothelium as a paracrine hormonal response in case of localized 
vasoconstriction events. It will be generated in response to hypoxia and 
produced by endothelial nitricoxide synthase which can be inducible or  
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Myocardial ischemia / infarct evaluation and treatment 
 
Any patient presenting with retrosternal chest pain is considered as acute 
coronary syndrome until proved otherwise. Initially patients are subjected to 
electrocardiogram and if no finding consistent with acute coronary event in 
ECG, we should not presume the patient is having non-cardiac chest pain. If 
patient has typical constant compressive or unexplainable chest pain, he 
should to subjected to echocardiography after initial hemodynamic 
evaluation and ECG. Patient should be started on antiplatelet therapy unless 
it is contraindicated. Hemodynamic stabilization should be the prime goal of 
treatment of acute chest pain patient. Serum marker of myocardial injury 
should be sent. Additional diuretic and antihypertensive treatment depends 
on the presentation. Statin therapy is nowadays is must that too in very high 
doses of 80 mg atorvastatin in initial therapy to reduce acute inflammation 
and should continued in low dose to maintain in isolipidemic state. 
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Here is a simple algorithm to explain the initial evaluation of any patient 
with cardiac pain 
It mainly focuses on to first exclude myocardial infarction (MI) 
It is not common to encounter with normal ECG, echo but those with 
inducible ischemia can be picked up with treadmill test. 
Even with pharmacological test, if a person comes with normal result, we 
should subject the patient to angiography if the symptoms recurs or persists 
and rule out early significant coronary stenosis   and continue the patient on 
antiplatelet therapy if needed. 
 
ACC/AHA guideline algorithm for acute coronary 
syndrome 
This guide line highlights the importance of stress test to provoke ischemia 
changes in a patient with normal resting ECG with no significant findings 
like ST, T changes or new bundle branch block.Assess LV function along 
with the stress test or after the stress study to assess future risks. 
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Initial evaluation in the emergency department focuses on identification of 
STEMI, early therapy, and reperfusion strategy. Selection of reperfusion 
strategy depends on hospital and patient characteristics, time to reperfusion 
therapy strongly determines outcomes in STEMI. Patients presenting within 
90 minutes to a hospital with percutaneous coronary intervention (PCI) 
capability should undergo PCI. Those with STEMI presenting to a hospital 
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not capable of doing PCI should be transferred to a PCI capable hospital 
based on patient characteristics, time from onset of symptoms, and time to 
reachhospital with PCI therapy. 
Those  STEMI patients presenting to a hospital without PCI capability,  who 
cannot be transferred to a center capable of doing PCI and where PCI can’t 
be done within 90 minutes of first medical contact should be offered 
fibrinolysis therapy in 30 minutes of hospitalization provided no 
contraindications exists for thrombolysis for that particular patient.  
 
The management of patients with hypotension, pulmonary edema, 
arrhythmias, or shock depends on the most likely underlying disorder. LV 
function and the presence of any aneurysm, septal rupture should be 
assessed by echocardiograph. 
 For those with low blood pressure treatment should include inotropic 
support if it’s due to right ventricular MI. suppose right ventricular MI is 
present, intravenous fluid rushing should be the first line of treatment and 
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later to decide on thrombolytic therapy. Other treatment options to save 
coronary perfusion includes intraaorticbaloon counter pulsation, mechanical 
reperfusion with percutaneous coronary intervention and once stabilized to 
undergo coronary artery bypass graft (CABG). 
Any aneurysm or septal infarct with communication should subjected to 
surgery immediately. 
Beta blockers or calcium channel blockers should not be administered in 
low cardiac output states. 
Contraindications for thrombolysis includesthose 
With intracranial hemorrhage 
AV malformations 
Ischemic stroke within 3 months 
Any Active bleeding diathesis 
Some are considered relative contraindications as listed below 
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Decision to select patient fit for reperfusion therapy should be made in 
quick succession so that any patient who is candidate to undergo 
percutaneous intervention should not fail to get treatment. 
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Keep ready with thrombolytic agent and proceed with angiogram and 
depending on the circumstances do medical intervention , PCI with stent 
insertion or if situations persists do primary CABG ( coronary artery bypass 
graft ) using the suitable vessel. Most commonly used one is left internal 
thoracic artery that is anastomosed to the left anterior descending artery. 
Other vessels used includes right internal thoracic artery, great saphenous 
vein and radial artery if necessary. 
The reason left internal thoracic artery preferred is due to its long patency 
and easy end to end anastomosis so that long duration of surgery also be 
minimized and ability to withstand shear force. Great saphenous vein has 
got poor patency but got an advantage multiple level harvesting possibility 
in that vein. 
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Algorithym for treatmet of a patient diagnosed with STEMI.
 
Methods to evaluate coronary stenosis 
Coronary stenosis can be measured by means of both invasive and non-
Invasive Methods. 
Invasive methods include 
Invasive angiogram. 
Intravascular ultra sonogram. 
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Non-invasive methods include 
MRI angiogram - which also gives myocardial contractive characteristics 
and ejection fraction. 
Single photon computed tomography 
128 slice MDCT -Multislice computed tomography – allows calcium 
scoring also. 
PET scan - which is expensive. 
Thallium201 myocardial imaging with rest exercise assessment of left 
ventricular function using radionuclide methods. 
CT ANGIOGRAM 
Apart from providing information regarding calcification, this also gives 
angiogram of coronary arterial tree. 
This gives the total calcium score. Provides information only for established 
or chronic stable angina and not in cases low risk cardiac pain patients. The 
benefit should weighted against risk of radiation exposure. When combined 
with PET scan termed PET-CT, myocardial perfusion and viability. 
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Cardiac MRI (CMR) 
This helps to additional imaging of aorta and major vessels status. When 
this combined with the pharmacological stress test, appears best comparable 
to SPECT. Provides information on anatomy of coronaries, LV function, 
blood flow, viability of myocardium. 
Stress Nuclear Myocardial Perfusion Imaging– 
Exercise perfusion imaging with concomitant ECG analysis is better than 
exercise ECG alonefor identifying CAD, vessel localization, and assessing 
extend of myocardial ischemic and infarcted regions. Exercise single-photon 
emission computed tomography (SPECT) yields an average sensitivity and 
specificity of 89% and 71%, compared with 67% sensitivity and 76% 
specificity for exercise ECG alone.Higher specificity of around 90% 
obtained after avoiding referring bias. Also helps in identifying viable tissue 
and assessing prognosis. 
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Pharmacologic Nuclear Stress Testing 
 
For those unable to exercise with effort, in older patients and those with 
PVD, COPD, arthritis, obesity individual, pharmacologic vasodilator stress 
with dipyridamole or adenosine derivatives is useful. This form of imaging 
is very much comparable to exercise perfusion imaging. But still treadmill 
testing is preferred for patients who can able to do exercising as exercise 
provides additional diagnostic and prognostic information, including ST-
segment changes, effort tolerance and symptomatic response, and HR and 
blood pressure monitoring. 
Vasodilator stress agents are also used with positron emission tomography 
to diagnose CAD and assess its severity. 
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Stress Echocardiography  
 
 
2D echocardiography is useful to assess the chronic CAD patients as it 
can assess focal and regional LV function during  normal and in 
ischemic conditions and also to assess the left ventricular hypertrophy 
and also cardiac valvular disease. Stress echocardiography may be done 
by usingboth exercise andpharmacologic agent’s helps us to identify the 
areas with regional wall motion abnormalities. Best images and 
diagnosis can be made in around 84% of patients. The test is a 
reproducible oneseveral studies have proved that stress 
echocardiography is superior to exercise ECG and stress cardiac 
imaging alone. This is also best in picking up areas of ischemic 
myocardium and localizing it. This has got good prognostic assessment 
capability. Pharmacologic stress ECHO using dobutamine should 
reservedfor patients unable to exercise, those unable to get required 
heart rate with exercise, and those who got poor images after exercise. 
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Stress echocardiography is best avoided in cases of patient having 
features of COPD. 
Patient should not smoke, eat or drink water four hours prior to the 
procedure. The procedure will take around half hour to one hour 
depending on patient’s cooperation and need to repeat in cases of errors. 
Drug induced stress echocardiography also takes around one hour for 
the procedure to complete. 
Nuclear Stress Test 
A Nuclear Stress Test is similar to a standard exercise treadmill stress 
test, using an isotope Cardiolite or Thallium to evaluate coronary blood 
flow. Also provides information on recoverable status of heart myocytes 
recovers after exercise, and arrhythmia. 
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Cardiac catheterization and angiography: 
Definitive diagnosis of CAD and precise assessment of its anatomic severity 
can be made by using catheterization and angiography only. The catheter 
can be accessed via radial or femoral artery and reached till the ascending 
aorta until cusps under the guidance of CT angiogram, where radioactive 
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dye is being injection after the catheter tip is inserted into origin of left 
coronary sinus and left coronary anatomy is first visualized guiding with 
dye injection into the left main coronary artery and after visualizing the left 
coronary anatomy with clear delineation in multiple views so as to visualize 
till the distal branches, the catheter is turned around and further inserted into 
the right coronary cusp and entered the right coronary sinus and dye is being 
injected into the right coronary artery with parallel view of the anatomy of 
right coronary system with the guidance of computed tomography. 
 
In patients with chronic stable angina, around 25% each have single, to 
triple vessel disease in coronary angiogram. 
 
INTRAVASCULAR ULTRSONOGRAPHY 
This one done with a mini ultrasound probe attached at the tip of the 
catheter and images is viewed in a monitor connected outside.it helps to 
visualize not only the plaque inside the lumen but also the hidden plaques 
within the vascular wall. 
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The Advanced invasive imaging like as intravascular ultrasonography 
provide a cross-sectional view of the coronary artery. This provides 
enhanced view and helps quantify coronary atherosclerosis, as identify those 
vessels got chance for future coronary atheroma. Studies incorporating both 
coronary angiography and IVUS have proved that the severity of coronary 
artery disease may be underestimated by angiography alone. 
 
Intravascular optical coherence tomography, angioscopy, and thermography 
are newer techniques and will be made routine in future for complete 
characterization of coronary atherosclerosis. 
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Cardiac catheter insertion 
Cardiac catheterization using seldinger technique 
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Left coronary artery in coronary angiogram 
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Right coronary artery in coronary angiogram 
 
Right coronary angiogram in PA cranial view showing lesion in proximal 
posterior descending artery. 
 
Modified gensini scoring 
The severity of coronary stenosis is assessed by using modified gensini 
scoring. 
This involves assigning fixed scoring based on percentage of compression 
of the lumen in coronaries and then multiplying it with the fixed factor 
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depending on the location of stenosis. This also describes the extent of 
lesion. 
The proximal portions of the coronaries caries more multiplying factor 
compared to the distal portions of coronaries.20% lumen narrowing carries a 
score of 1 and it gradually increased in terms of 50,75,90,99 and 100 
percent stenosis with the score of 2, 4,8,16and 32 respectively. 
 
This score concentrates not on the number of branches involved but the 
region of artery involved and the percentage of luminal occlusion which is 
more important than the number of vessels involved. This gives more 
importance to those vessel which supplies majority of myocardium and 
resultant percentage of myocardium being infarcted. 
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The multiplying factors is given as follows 
Left main stem – 2.5 x 
LAD proximal – 2.5 x 
LAD mid – 1.5 x 
LAD distal – 1 x 
First degree diagonal – 1x   &   Second degree diagonal -0.5 
Left circumflex proximal – 2.5x, distal – 1x 
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Left diagonal and marginal branch – 1x 
Left poster lateral branch – 0.5x 
Right coronary artery proximal, mid and distal – 1x 
 
 
Balloon angioplasty 
This procedure involves cardiac catheterization as usual and balloon which 
is inflated after assessing the plaque size and the appropriate air inflation is 
done so as to compress the plaque and attain the desired lumen size post 
ballooning. The balloon in inflated for sixty to ninety seconds and repeated 
if required. 
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Coronary stent placement using balloon guidance 
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Coronary artery bypass graft 
This is the last sort of treatment when either medication and balloon 
angioplasty fails to relieve disease or can be a part of primary treatment 
depending on the severity of lesion and persistence of symptoms. 
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AIMS AND OBJECTIVES 
 
 
1. TO STUDY CORRELATION OF VARIOUS ANTHROPOMETRIC 
MEASURES AND SERUM HOMOCYSTEINE LEVEL WITH THE 
SEVERITY OF CORONARY ARTERY DISEASE. 
 
 
 
2. TO IDENTIFY STRONG ANTHROPOMETRIC PARAMETER 
CORRELATING WITH THE SEVERITY OF CORONARY ARTERY 
DISEASE USING CAG. 
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MATERIALS AND METHODS 
 
PLACE OF STUDY: 
 
HUTTON WARD, DEPARTMENT OFCARDIOLOGY,   STANELY MEDICAL 
COLLEGE AND HOSPITAL, CHENNAI. 
 
DURATION: 
 
 NOV 2013 TO SEP 2014 
STUDY DESIGN 
 
PROSPECTIVE AND OBSERVATIONAL STUDY  
 
SOURCE OF DATA: 
 
PATIENTS WITH HISTORY OF CHEST PAIN WHO FULFILL THE INCLUSION 
AND EXCLUSION CRITERIA, GETTING ADMITTED AT CARDIOLOGY 
HUTTON WARD,  STANLEY MEDICAL COLLEGE, CHENNAI DURING THE 
PERIOD OF NOV 2013 TO SEPTEMBER 2014 AND PLANNED FOR CORONARY 
ANGIOGRAM. 
SAMPLE SIZE: 
  75 
INCLUSION CRITERIA:  
1. ALL PATIENTS UNDER 50YRS OF AGE , ADMITTED IN CARDIOLOGY 
DEPARTMENT HUTTON WARD, STANLEY MEDICAL COLLEGE FOR 
UNDERGOING CORONARY ANGIOGRAM 
 
EXCLUSION CRITERIA: 
1. PATIENTS KNOWN TO HAVE RHEUMATIC HEART DISEASE, 
ISCHEMIC DCMP. 
2. PATIENTS WHO ARE ABOVE THE AGE OF 50 YRS. 
3. PATIENTS WHO ARE CHRONIC ALCOHOLICS. 
4. PATIENTS WITH CHRONIC KIDNEY DISEASE. 
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5. PATIENTS WITH ASCITES AND OTHER INTRABDOMINAL 
PATHOLOGY. 
6. PATIENTS WITH HB < 11GM% 
 
 
METHODOLOGY 
 
 
Patients admitted for angiography between November 2013 to 
September 2014 will be included in the study. 
DATA COLLECTED USING A PROFOMA MEETING THE OBJECTIVES OF 
THE STUDY. 
 DETAILED HISTORY, PHYSICAL EXAMINATION AND NECESSARY 
INVESTIGATIONS WILL BE UNDERTAKEN. 
They are subjected for anthropometry measurements including height, 
weight, BMI, hip and waist circumference, WHR, sagittal abdominal 
diameter, triceps skin fold thickness and SAD/TSFT ratio measured. 
Also their serum homocysteine level, glycemic status, Presence or 
absence of hypertension and diabetes, smoking and alcohol intake with 
duration, life style & physical activity, frequency of chest pain, ECG 
findings and echo status will be noted prior to angiogram. 
Post angiogram evaluation of severity of coronary artery stenosis made my 
Modified Gensini Score. 
 
THE PURPOSE OF THE STUDY WILL BE EXPLAINED TO THE PATIENT AND 
INFORMED CONSENT OBTAINED 
THE ANALYSIS OF THE DATA WILL BE DONE USING APPROPRIATE 
STATISTICAL METHODS. 
 
 
 72 
 
Results and discussion 
The study includes total number of 75 patients. Data were 
collected and final analysis were made. 
 
Study Groups 
Study Groups Name of Group 
CAG 
Findings 
Number of 
Subjects 
Group A 
Non critical CAD 
 
Normal and 
Non 
obstructive 
(without a 
noncritical 
coronary 
Lesion) 
21 
Group B Critical CAD 
SVD, DVD, 
TVD 
(having at least 
one lesion more 
than 50% within 
the main 
branches 
of the coronary 
arteries) 
54 
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Statistics  
 
 
Descriptive statistics was done for all data and suitable statistical tests of 
comparison were done. Continuous variables were analysed with Unpaired 
t-test and categorical variables were analysed with the Chi-Square Test and 
Fisher Exact Test. Statistical significance was taken as P < 0.05. The data 
was analysed using EpiInfo software (7.1.0.6 version; Center for disease 
control, USA) and Microsoft Excel 2010. 
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Sample Size Calculation 
Sample size was determined on the basis of a pilot study in which the 
presence increased percentage of homocysteine levels was measured at 5%.  
We calculated a minimum sample size of 73 patients was required, 
assuming a type 1 error (two-tailed) of 0.05 and a margin of error of 10%. 
Therefore, the final sample selected was n=75. 
 
n= t² x p(1-p) 
  m² 
Description: 
n = required sample size 
t = confidence level at 95% (standard value of 1.96) 
p = estimated prevalence of malnutrition in the project area 
m = margin of error at 10% (standard value of 0.05) 
 
n= 
(1.96)² x 0.05(1-
0.95) 
             (0.05)² 
 
n= 3.8146 x 0.0474 
  
           0.0025 
 
= 73 
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Age  
 
 
 
Age 
Distribution 
All 
Patients 
% Group 1 % Group 2 % 
31 to 40 years 9 12.00 4 19.05 5 9.26 
41 to 50 years 66 88.00 17 80.95 49 90.74 
Total 75 100 21 100 54 100 
 
 
Age Distribution Group 1 Group 2 
N 21 54 
MEAN 44.62 46.07 
SD 3.81 3.32 
t test 0.134229994 
 
 
By conventional criteria the association between the study groups and age is 
considered to be not statistically significant since p > 0.05 
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Gender  
 
 
 
Gender 
Distribution 
All 
Patients 
% Group 1 % Group 2 % 
Male 51 68.00 12 57.14 39 72.22 
Female 24 32.00 9 42.86 15 27.78 
Total 75 100 21 100 54 100 
Chi-square value 1.58 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.209 
 
By conventional criteria the association between the study groups and 
gender is considered to be not statistically significant since p > 0.05. 
 
Since age and gender is not statistically significant, it means that there is no 
difference between the groups. In other words the groups contain subjects 
with the same basic demographic characteristics. 
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Smoking  
 
 
 
Smoking 
Status 
All Patients % Group 1 % Group 2 % 
Non Smoker 42 56.00 15 71.43 27 50.00 
Smoker 33 44.00 6 28.57 27 50.00 
Total 75 100 21 100 54 100 
Chi-square value 2.82 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.093 
 
By conventional criteria the association between the study groups and 
smoking among study subjects is considered to be statistically not 
significant since p > 0.05.  
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Duration of Smoking 
 
 
Duration of 
Smoking 
All 
Patients 
% Group 1 % Group 2 % 
≤ 10 years 24 72.73 6 100.00 18 66.67 
11 to 20 years 3 9.09 0 0.00 3 11.11 
> 20 years 6 18.18 0 0.00 6 22.22 
Total 33 100 6 100 27 100 
 
 
Duration of Smoking Group 1 Group 2 
N 6 27 
MEAN 2.00 9.93 
SD 0.89 11.02 
t test 0.0009 
 
 
By conventional criteria the association between the study groups and 
duration of smoking among study subjects is considered to be statistically 
significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the duration of smoking in 
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Group 1 (2 years) is predominantly less when compared to Group 2 (9.93 
years). It is statistically significant with a p-value of 0.0009 according to 
unpaired t test. 
 
 
Clinical Significance 
 
The duration of smoking in Group 1 is meaningfully less than Group 2 by 
4.96 times with a mean difference of 7.93 years. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in smokers with increased duration of smoking 
among our study subjects 
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Diet  
 
 
 
Diet Status 
All 
Patients 
% Group 1 % Group 2 % 
Vegetarian 9 12.00 4 19.05 5 9.26 
Non Vegetarian 66 88.00 17 80.95 49 90.74 
Total 75 100 21 100 54 100 
Chi-square value 1.03  
Degrees of freedom 1 
P value 
Chi Squared Test 
0.309 
 
By conventional criteria the association between the study groups and diet 
status among study subjects is considered to be statistically not significant 
since p > 0.05.  
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HT 
 
 
 
 
Hypertension 
Status 
All 
Patients 
% Group 1 % Group 2 % 
Normal 29 61.33 12 57.14 17 31.48 
Hypertensive 46 38.67 9 42.86 37 68.52 
Total 75 100 21 100 54 100 
Chi-square value 4.20 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.040 
 
 
 
By conventional criteria the association between the study groups and 
hypertension distribution status among study subjects is considered to be 
statistically significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the hypertension distribution 
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status in Group 1 (42.86% hypertensives) is predominantly less when 
compared to Group 2 (68.52% hypertensives). It is statistically significant 
with a p-value of 0.040 according to chi squared test. 
 
 
Clinical Significance 
 
The hypertension distribution status in Group 1 is meaningfully less than 
Group 2 by 1.60 times with a mean difference of 25.66 percentage points. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in hypertensive among our study subjects.  
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Duration of HT 
 
 
 
 
Duration of 
Hypertension 
All 
Patients 
% Group 1 % Group 2 % 
≤ 3 years 19 65.52 8 66.67 11 64.71 
4 to 5 years 7 24.14 4 33.33 3 17.65 
> 5 years 3 10.34 0 0.00 3 17.65 
Total 29 100 12 100 17 100 
 
Duration of Hypertension Group 1 Group 2 
N 12 17 
MEAN 3.00 3.06 
SD 1.71 2.07 
t test 0.9339 
 
By conventional criteria the association between the study groups and 
duration ofhypertension is considered to be not statistically significant since 
p > 0.05 
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DM 
 
 
 
Diabetes 
Status 
All Patients % Group 1 % Group 2 % 
Normal 39 52.00 11 52.38 28 51.85 
Diabetic 36 48.00 10 47.62 26 48.15 
Total 75 100 21 100 54 100 
Chi-square value 0.170 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.967 
 
 
By conventional criteria the association between the study groups and 
diabetes mellitus distribution status is considered to be not statistically 
significant since p > 0.05 
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DM Duration 
 
 
 
Duration of 
Diabetes 
All 
Patients 
% Group 1 % Group 2 % 
≤ 5 years 28 89.33 10 100.00 18 69.23 
6 to 10 years 6 8.00 0 0.00 6 23.08 
> 10 years 2 2.67 0 0.00 2 7.69 
Total 36 100 10 100 26 100 
 
 
By conventional criteria the association between the study groups and 
duration of diabetes mellitus among study subjects is considered to be 
statistically significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the duration of diabetes 
mellitus in Group 1 (2.90 years) is predominantly less when compared to 
Group 2 (5.65 years). It is statistically significant with a p-value of 0.0162 
according to unpaired t test. 
 
 
Clinical Significance 
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The duration of diabetes mellitus in Group 1 is meaningfully less than 
Group 2 by 1.95 times with a mean difference of 2.75 years. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased duration of diabetes 
mellitus among our study subjects 
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BMI 
 
 
 
BMI Status 
All 
Patients 
% Group 1 % Group 2 % 
18.50 to 24.99 
(Normal) 
28 37.33 9 42.86 19 35.19 
25 to 29.99 
(Overweight) 
40 53.33 11 52.38 29 53.70 
≥ 30 (Obese) 7 9.33 1 4.76 6 11.11 
Total 75 100 21 100 54 100 
 
 
BMI Status Group 1 Group 2 
N 21 54 
MEAN 25.23 26.11 
SD 2.85 3.54 
t test 0.2688 
 
By conventional criteria the association between the study groups and BMI 
distribution status is considered to be not statistically significant since p > 
0.05 
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WHR 
 
 
 
 
Waist Hip 
Ratio 
All Patients % Group 1 % Group 2 % 
≤ 0.85 7 9.33 4 19.05 3 5.56 
0.86 to 0.95 25 33.33 12 57.14 13 24.07 
> 0.95 43 57.33 5 23.81 38 70.37 
Total 75 100 21 100 54 100 
 
 
Groups Count Mean % 
Non Critical CAD 21 0.86 28 
SVD 33 0.93 44 
DVD 9 0.95 12 
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TVD 12 1.00 16 
Total 75 
 
100 
 
 
Waist Hip Ratio Group 1 Group 2 
N 21 54 
MEAN 0.91 1.04 
SD 0.04 0.06 
t test 0.0001 
 
By conventional criteria the association between the study groups and waist 
hip ratio among study subjects is considered to be statistically significant 
since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the waist hip ratio in Group 1 
(0.91) is predominantly less when compared to Group 2 (1.04). The waist 
hip ratio in non-critical CAD group (0.86) is predominantly less when 
compared to SVD(0.93), DVD(0.95) and TVD(1.00) groups It is statistically 
significant with a p-value of 0.0001 according to unpaired t test. 
 
Clinical Significance 
 
The waist hip ratio inGroup 1 is meaningfully less than Group 2 by 1.12 
times with a mean difference of 0.13 measurement points. 
 
The waist hip ratio in non-critical CAD group is meaningfully less than 
SVD group by 1.08 times with a mean difference of 0.07 measurement 
points. 
 
The waist hip ratio in non-critical CAD group is meaningfully less than 
DVD group by 1.10 times with a mean difference of 0.09 measurement 
points. 
 
The waist hip ratio in non-critical CAD group is meaningfully less than 
TVD group by 1.16 times with a mean difference of 0.14 measurement 
points. 
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This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased waist hip ratio among 
our study subjects. 
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SAD 
 
 
 
 
 
 
 
 
 
 
 
Sagittal 
Abdominal 
Diameter 
All 
Patients 
% Group 1 % Group 2 % 
≤ 22 cm 58 77.33 21 100.00 37 68.52 
22.1 to 24 cm 16 21.33 0 0.00 16 29.63 
> 24 cm 1 1.33 0 0.00 1 1.85 
Total 75 100 21 100 54 100 
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Groups Count Mean % 
Non Critical CAD 21 20.81 28 
SVD 33 21.12 44 
DVD 9 21.73 12 
TVD 12 22.55 16 
Total 75 
 
100 
 
Sagittal Abdominal Diameter Group 1 Group 2 
N 21 54 
MEAN 20.81 21.80 
SD 0.87 1.33 
t test 0.0004 
 
 
By conventional criteria the association between the study groups and 
sagittal abdominal diameter among study subjects is considered to be 
statistically significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the sagittal abdominal diameter 
in Group 1 (20.81 cm) is predominantly less when compared to Group 2 
(21.80 cm). The sagittal abdominal diameter in noncritical CAD 
group(20.81 cm) is predominantly less when compared to SVD(21.12 cm), 
DVD(21.73 cm) and TVD(1.00) groups It is statistically significant with a 
p-value of 0.0001 according to unpaired t test. 
It is statistically significant with a p-value of 0.0004 according to unpaired t 
test. 
 
Clinical Significance 
 
The sagittal abdominal diameter in Group 1 is meaningfully less than Group 
2 by 1.05 times with a mean difference of 0.98 cm. 
 
The sagittal abdominal diameter in non-critical CAD group is meaningfully 
less than SVD group by 1.01 times with a mean difference of 0.31 cm. 
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The sagittal abdominal diameter in non-critical CAD group is meaningfully 
less than DVD group by 1.04 times with a mean difference of 0.92 cm. 
 
The sagittal abdominal diameter in non-critical CAD group is meaningfully 
less than TVD group by 1.08 times with a mean difference of 1.74 cm. 
 
 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased sagittal abdominal 
diameter among our study subjects. 
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TSFT 
 
 
 
 
 
Triceps Skin 
Fold 
Thickness 
All 
Patients 
% Group 1 % Group 2 % 
≤ 3.5 cm 41 54.67 6 28.57 35 64.81 
3.6 to 4 cm 26 34.67 12 57.14 14 25.93 
> 4 cm 8 10.67 3 14.29 5 9.26 
Total 75 100 21 100 54 100 
 
Groups Count Mean % 
Non Critical CAD 21 3.81 28 
SVD 33 3.74 44 
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DVD 9 3.59 12 
TVD 12 3.12 16 
Total 75 
 
100 
 
 
Triceps Skin Fold Thickness Group 1 Group 2 
N 21 54 
MEAN 3.74 3.52 
SD 0.33 0.58 
t test 0.0457 
 
By conventional criteria the association between the study groups and 
Triceps Skin Fold Thickness among study subjects is considered to be 
statistically significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the Triceps Skin Fold 
Thickness in Group 1 (3.74 cm) is predominantly more when compared to 
Group 2 (3.52cm). The Triceps Skin Fold Thicknessin non-critical CAD 
group (3.81cm) is predominantly more when compared to SVD (3.74 cm), 
DVD (3.59 cm) and TVD (3.21 cm) groups. It is statistically significant 
with a p-value of 0.0457 according to unpaired t test. 
 
Clinical Significance 
 
The Triceps Skin Fold Thickness in Group 1 is meaningfully more than 
Group 2 by 1.06 times with a mean difference of 0.22 cm. 
 
The Triceps Skin Fold Thickness in non-critical CAD group is meaningfully 
more than SVD group by 1.02 times with a mean difference of 0.07 cm. 
 
The Triceps Skin Fold Thickness in non-critical CAD group is meaningfully 
more than DVD group by 1.06 times with a mean difference of 0.22 cm. 
 
The Triceps Skin Fold Thickness in non-critical CAD group is meaningfully 
more than TVD group by 1.22 times with a mean difference of 0.69 cm. 
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This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with decreased Triceps Skin Fold 
Thickness among our study subjects. 
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SAD/TSFT 
 
 
 
 
 
 
SAD/TSFT 
All 
Patients 
% Group 1 % Group 2 % 
≤ 5 7 9.33 3 14.29 4 7.41 
5.1 to 10 68 90.67 18 85.71 50 92.59 
Total 75 100 21 100 54 100 
 
 
Groups Count Mean % 
Non Critical CAD 21 5.61 28 
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SVD 33 5.91 44 
DVD 9 6.09 12 
TVD 12 7.29 16 
Total 75 
 
100 
 
 
 
SAD/TSFT Ratio Group 1 Group 2 
N 21 54 
MEAN 5.61 6.32 
SD 0.55 0.96 
t test 0.0001 
 
By conventional criteria the association between the study groups and 
SAD/TSFT ratio among study subjects is considered to be statistically 
significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the SAD/TSFT ratio in Group 1 
(5.61) is predominantly less when compared to Group 2 (6,32). The 
SAD/TSFT ratio in noncritical CAD group(5.61) is predominantly less 
when compared to SVD(5.91), DVD(6.09) and TVD(7.29) groups  .It is 
statistically significant with a p-value of 0.0001 according to unpaired t test. 
 
Clinical Significance 
 
The SAD/TSFT ratio in Group 1 is meaningfully less than Group 2 by 1.13  
times with a mean difference of 0.72 measurement points. 
 
The SAD/TSFT ratio in non-critical CAD group is meaningfully less than 
SVD group by 1.05 times with a mean difference of 0.30 measurement 
points. 
 
The SAD/TSFT ratio in non-critical CAD group is meaningfully less than 
DVD group by 1.09 times with a mean difference of 0.48 measurement 
points. 
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The SAD/TSFT ratio in non-critical CAD group is meaningfully less than 
TVD group by 1.30 times with a mean difference of 1.68 measurement 
points. 
 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased SAD/TSFT ratio 
among our study subjects. 
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HOMOCYSTEINE  
 
 
 
 
 
Homocysteine 
Levels 
All 
Patients 
% Group 1 % Group 2 % 
≤ 10 nmol/lit 44 58.67 18 85.71 26 48.15 
10.1 to 15 
nmol/lit 
14 18.67 2 9.52 12 22.22 
> 15 nmol/lit 17 22.67 1 4.76 16 29.63 
Total 75 100 21 100 54 100 
 
Groups Count Mean % 
Non Critical CAD 21 6.50 28 
SVD 33 8.23 44 
DVD 9 15.99 12 
TVD 12 33.85 16 
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Total 75 
 
100 
 
 
Homocysteine Levels Group 1 Group 2 
N 21 54 
MEAN 6.50 15.22 
SD 3.59 13.63 
t test 0.0000 
 
By conventional criteria the association between the study groups and serum 
homocysteine levels among study subjects is considered to be statistically 
significant since p < 0.05.  
 
 
Statistical Significance 
 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum homocysteine level 
along with the severity of coronary stenosis, the serum homocysteine levels 
in Group 1 (6.50 nmol/lit) is predominantly less when compared to Group 2 
(15.22 nmol/lit). The serum homocysteine levels in noncritical CAD 
group(6.50 nmol/lit) is predominantly less when compared to SVD(8.23 
nmol/lit), DVD(15.99 nmol/lit) and TVD(33.85 nmol/lit) groups  .It is 
statistically significant with a p-value of 0.0000 according to unpaired t test. 
 
Clinical Significance 
 
The serum homocysteine levels in Group 1 is meaningfully less than Group 
2 by 2.34 times with a mean difference of 8.72  nmol/lit. 
 
The serum homocysteine levels in non-critical CAD group is meaningfully 
less than SVD group by 1.27 times with a mean difference of 1.73 nmol/lit. 
 
The serum homocysteine levels in non-critical CAD group is meaningfully 
less than DVD group by 2.46 times with a mean difference of 9.49 nmol/lit.  
 
The serum homocysteine levels in non-critical CAD group is meaningfully 
less than TVD group by 5.20 times with a mean difference of 27.35 
nmol/lit.  
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This difference is true and significant and has not occurred by chance. 
 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased serum homocysteine 
levels among our study subjects. 
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SBP 
 
 
 
Systolic BP Status 
All 
Patients 
% Group 1 % Group 2 % 
≤ 120 mm hg 34 46.67 12 57.14 22 40.74 
121 to 140 mm 
hg 
30 38.67 6 28.57 24 44.44 
> 140 mm hg 11 14.67 3 14.29 8 14.81 
Total 75 100 21 100 54 100 
 
Systolic BP Status Group 1 Group 2 
N 21 54 
MEAN 126.48 131.22 
SD 14.24 18.58 
t test 0.2420 
 
 
By conventional criteria the association between the study groups and 
systolic BP distribution status is considered to be not statistically significant 
since p > 0.05 
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DBP 
 
 
 
Diastolic BP 
Status 
All 
Patients 
% Group 1 % Group 2 % 
≤ 80 mm hg 55 73.33 17 80.95 38 70.37 
81 to 100 mm hg 17 21.33 4 19.05 13 24.07 
> 100 mm hg 3 5.33 0 0.00 3 5.56 
Total 75 100 21 100 54 100 
 
 
Diastolic BP Status Group 1 Group 2 
N 21 54 
MEAN 77.81 81.15 
SD 10.99 10.07 
t test 0.2351 
 
By conventional criteria the association between the study groups and 
diastolic BP distribution status is considered to be not statistically 
significant since p > 0.05 
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LDL 
 
 
LDL Status 
All 
Patients 
% Group 1 % Group 2 % 
≤ 100 mg/dl 44 64.00 16 76.19 28 51.85 
101 to 130 mg/dl 29 36.00 5 23.81 24 44.44 
> 130 mg/dl 2 0.00 0 0.00 2 3.70 
Total 75 100 21 100 54 100 
 
 
LDL Status Group 1 Group 2 
N 21 54 
MEAN 94.24 100.52 
SD 9.18 12.76 
t test 0.0217 
 
 
By conventional criteria the association between the study groups and serum 
LDL levels among study subjects is considered to be statistically significant 
since p < 0.05.  
 
 
Statistical Significance 
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This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum LDL level along with 
the severity of coronary stenosis, the serum homocysteine levels in Group 1 
(9.24 mg/dl) is predominantly less when compared to Group 2 (100.52 
mg/dl). It is statistically significant with a p-value of 0.0217 according to 
unpaired t test. 
 
Clinical Significance 
 
The serum LDL levels in Group 1 is meaningfully less than Group 2 by 1.07 
times with a mean difference of 6.28 mg/dl. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased serum LDL levels 
among our study subjects. 
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HDL 
 
 
 
HDL Status 
All 
Patients 
% Group 1 % Group 2 % 
≤ 40 mg/dl 32 42.67 8 38.10 24 44.44 
41 to 60 mg/dl 43 57.33 13 61.90 30 55.56 
> 60 mg/dl 0 0.00 0 0.00 0 0.00 
Total 75 100 21 100 54 100 
 
 
HDL Status Group 1 Group 2 
N 21 54 
MEAN 41.71 41.56 
SD 5.00 5.94 
t test 0.9074 
 
By conventional criteria the association between the study groups and serum 
HDL levels is considered to be not statistically significant since p > 0.05 
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LVEF 
 
 
 
LVEF (%) 
Status 
All Patients % Group 1 % Group 2 % 
≤ 40 % 14 17.33 1 4.76 13 24.07 
41 to 55 % 40 53.33 6 28.57 34 62.96 
56 to 70 % 21 29.33 14 66.67 7 12.96 
Total 75 100 21 100 54 100 
 
 
LVEF (%) Status Group 1 Group 2 
N 21 54 
MEAN 57.19 45.56 
SD 6.92 6.56 
t test 0.0000 
 
 
By conventional criteria the association between the study groups and 
LVEF% status among study subjects is considered to be statistically 
significant since p < 0.05.  
 
 
Statistical Significance 
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This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum LDL level along with 
the severity of coronary stenosis, the LVEF% status in Group 1 (57.19%) is 
predominantly more when compared to Group 2 (45.56%). It is statistically 
significant with a p-value of 0.0217 according to unpaired t test. 
 
Clinical Significance 
 
The LVEF% statusin Group 1 is meaningfully more than Group 2 by 1.25 
times with a mean difference of 11.63 percentage measurement points. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with decreased LVEF% status among 
our study subjects. 
  
 110 
 
GENSINI  
 
 
CAG-
MODIFIED 
GENSINI 
SCORING 
All 
Patients 
% Group 1 % Group 2 % 
≤ 25 55 73.33 21 100.00 34 62.96 
26 to 50 11 14.67 0 0.00 11 20.37 
50 to 100 9 12.00 0 0.00 9 16.67 
Total 75 100 21 100 54 100 
 
CAG-MODIFIED GENSINI 
SCORING 
Group 1 Group 2 
N 21 54 
MEAN 1.10 30.19 
SD 1.37 23.32 
t test 0.0000 
 
 
By conventional criteria the association between the study groups and 
Gensini scores among study subjects is considered to be statistically 
significant since p < 0.05.  
 
 
Statistical Significance 
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This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, when studying the association 
between various anthropometric measures and serum LDL level along with 
the severity of coronary stenosis, the Gensini scores in Group 1 (1.10 
points) is predominantly less when compared to Group 2 (30.19 points). It is 
statistically significant with a p-value of 0.0000 according to unpaired t test. 
 
Clinical Significance 
 
The Gensini scoresin Group 1 is meaningfully less than Group 2 by 27.56 
times with a mean difference of 29.09 scoring points. 
 
This difference is true and significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
increased coronary stenosis in patients with increased Gensini scores among 
our study subjects. 
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DIAGNOSIS 
 
 
Diagnosis 
All 
Patients 
% Group 1 % Group 2 % 
STEMI 11 61.33 6 28.57 5 9.26 
NSTEMI 47 16.00 4 19.05 43 79.63 
Unstable Angina 17 22.67 11 52.38 6 11.11 
Total 75 100 21 100 54 100 
 
 
Diagnosis Group 1 Group 2 
N 21 54 
MEAN 2.24 2.02 
SD 0.89 0.46 
t test 0.2916 
 
By conventional criteria the association between the study groups and 
diagnosis at the time of admission is considered to be not statistically 
significant since p > 0.05 
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    CITATIONS 
A. Vasheghani-Farahani et al.showed SAD-to-TSF ratio, has a 
substantially better accuracythan do the known indices of obesity like body 
mass index, waist circumference, and waist-to-hip ratiofor the prediction of 
premature CAD. He found that sagittal abdominal diameter to triceps 
skinfold thickness ratio as a novel anthropometric index to predict 
premature coronaryAtherosclerosis. 
 
 
AC Carlsson et alin his study tried to establish Novel and established 
anthropometric measures and the predictionof incident cardiovascular 
disease: a cohort study and found that WHHR, a measure reflecting body fat 
distribution, showed the highest risk estimates after adjustments 
forestablished CVD risk factors. These findings were verified in men but 
not women in an independent cohort. 
R Abraham et al studied on homocysteine level and foundraised serum 
homocysteine levels in patients of coronary Artery disease and the effect of 
vitamin b12 and folate on its Concentration. 
 
Kazemimb et al in one study found hyperhomocysteinemia is related to 
CAD as an independent risk factor. In individuals without any risk factors a 
linear correlation between homocysteine level and numbers of coronary 
artery involvement was present 
Kahn et al proposed that ADI might be more effective atestimating visceral 
adipose tissue and, hence, a better predictor ofCVD than WHR 
 
Wilken et al published the first reportthat patients with coronary artery 
disease haveabnormal homocysteine metabolism. 
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CONCLUSION 
In my study using 75 patients under 50 years, I am able to come to a 
conclusion of some anthropometric variables better correlating with the 
severity of coronary stenosis and some not showing much correlation as 
listed below 
1) Increased Waist-hip ratio, sagittal abdominal diameter, triceps skin 
fold thickness and SAD/TSFT ratio has got better correlation with 
the severity of coronary artery disease, with SAD/TSFT and WHR 
has got maximum significance of all anthropometric measurements. 
2) Increased BMI poorly correlating with the severity of CAD as 
shown by p value more than 0.05. 
3) Increased homocysteine level better correlates with the severity of 
coronary artery disease. 
4) Increased LDL cholesterol value had good correlation with CAD 
severity butdecreased HDL cholesterol not correlating much with 
coronaryartery disease. 
5) Duration of smoking but not mere smoking history better correlates 
with the severity of coronaryartery disease.Smoking is found to be 
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an independent high risk factor even in patients with low BMI, low 
waist or hip circumference and low WHR or SAD/TSFT ratio. 
6) Presence of hypertension and duration of diabetes got positive 
correlation on coronary artery disease severity. 
7) Left ventricular ejection fraction (LVEF) also correlates with the 
severity of coronary artery disease with an inverse relation between 
them. 
8) Modified gensini score – higher the modified gensini score, severe 
is the coronary artery disease. 
9) It appears that the old concept of BMI being considered as major 
risk factor in the past will not apply nowadays as an important 
determinant for CAD risk assessment, as it is shown in our study 
and in many major studies to be statistically less significant and it’s 
better to give importance to central Vs peripheral obesity ratio 
methods to assess future risk of CAD. 
10) We feel great emphasis should be given on cessation of smoking 
compared to control of obesity as it’s a major atherosclerotic risk 
factor even in thin individuals and those patients are prone for CAD 
at very young age. 
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PROFORMA 
NAME :        SL. NO:  
AGE /SEX:  
OCCUPATION: 
ADDRESS WITH CONTACT NUMBER:  
  
 
IP NO:  
DATE OF ADMISSION:  
DATE OF DISCHARGE:  
 
HISTORY: 
CHEST PAIN  
Duration 
Severity 
Pain radiation 
BREATHLESSNESS 
ORTHOPNEA 
PND 
LEG SWELLING 
FACIAL PUFFINESS 
 
PAST HISTORY 
HYPERTENSION 
DIABETES 
CAD 
CVD 
COPD 
CKD 
PERSONAL HISTORY 
SMOKER  
ALCOHOLIC 
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PHYSICAL EXAMINATION 
 
PALLOR 
ICTERUS 
CYANOSIS 
CLUBBING 
PEDAL EDEMA  
JVP 
BP:                          
 PR:                           
 
HEIGHT  
WEIGHTS 
BMI 
WAIST CIRCUMFERENCE 
HIP CIRCUMFERENCE 
WAIST HIP RATIO 
SAGITTAL ABDOMINAL CIRCUMFERENCE 
TRICEPS SKIN FOLD THICKNESS 
SAD/TSFT 
 
CVS - 
RS - 
P/A -  
CNS – 
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INVESTIGATIONS 
CBC – TC 
DC 
ESR 
HB 
PLATELETS 
BLOOD SUGAR 
               UREA 
SERUM CREATININE 
                SODIUM 
                POTASSIUM 
                CHLORIDE 
                BICARBONATE 
BLOOD GROUP 
VIRAL MARKERS 
SERUM HOMOCYSTEINE LEVEL 
URINE EXAMINATION 
TOTAL CPK 
CPK-MB LEVEL 
ECG 
ECHOCARDIOGRAPHY 
SEVERITY OF CORONARY STENOSIS USING MODIFIED GENSINI 
SCORING 
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GOVT.STANLEY MEDICAL COLLEGE, CHENNAI- 600 001 
 
INFORMED CONSENT 
 
DISSERTATION TOPIC: “A STUDY ON CORRELATION OF VARIOUS 
ANTHROPOMETRIC MEASURES AND SERUM HOMOCYSTEINE LEVEL WITH THE 
SEVERITY OF CORONARY ARTERY DISEASE IN YOUNG PATIENTS UNDERGOING 
CORONARY ANGIOGRAPHY” 
 
PLACE OF STUDY: HUTTON WARD, DEPARTMENT OF CARDIOLOGY,   
STANELY MEDICAL COLLEGE AND HOSPITAL, CHENNAI. 
 
NAME AND ADDRESS OF PATIENT: 
 
I, _____________________ have been informed about the details of the study in my 
own language. 
 
I have completely understood the details of the study. 
 
I am aware of the possible risks and benefits, while taking part in the study. 
 
I understand that I can withdraw from the study at any point of time and even then, I 
will continue to receive the medical treatment as usual. 
 
I understand that I will not get any payment for taking part in this study. 
 
I will not object if the results of this study are getting published in any medical journal, 
provided my personal identity is not revealed. 
 
I know what I am supposed to do by taking part in this study and I assure that I would 
extend my full co-operation for this study. 
 
Name and Address of the Volunteer:  
 
Signature/Thumb impression of the Volunteer 
 
Date: 
 
Witnesses: 
(Signature, Name & Address) 
 
Date: 
Name and signature of investigator: 
 
Date: 
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மனிதரளவையியல் அளவுருக்கள் மற்றும் இரத்த 
ஹ ோஹமோசிஷ்டின் அளவையும் கஹரோனரி தமனியின் 
குறுக்கத்தின் தைீிரத்ஹதோடு ஒப்பிடும் ஒரு ஆய்வு 
 
ஆய்வாளர்: மரு.ஹகோ.சுஹரஷ்  ( முதுநிலை பட்டமேற்படிப்பு ோணவர், ப ொது 
மருத்துவ பட்டபடிப்பு) 
 
வழிகாட்டி: மரு.க.தமிழ்பெல்வன் ( இருதய மருத்துவ துணை மபராசிரியர் ) 
அரசு ஸ்டான்ைி ேருத்துவேலை. 
 
பங்கேற்பாளரின் தேவல் படிவம் 
 
நீங்கள் இந்த ஆய்வில் பங்மகற்க அலழக்கப்படுகிறரீ்கள். இந்த ஆய்வில் பங்மகற்கும் முன், இதன் 
மநாக்கத்லதயும், முலறகலளயும், இதைால் ஏற்படும் பின்விலளவுகலளயும் நீங்கள் அறிந்து 
ககாள்ள ஆய்வாளர் அளிக்கும் தகவல்: 
உங்கள் மநாயின் வரைாறும், உங்களின் முழு உடல் பரிமசாதலையும் கதளிவாகவும் 
விரிவாகவும் பதிவு கசய்யப்படும். 
இந்த ஆய்வின் முடிவுகள் ேருத்துவ காரணங்களுக்காகவும், ேருத்துவ கல்விக்காகவும் 
பயன்படுத்தப்படும். இந்த ஆய்வு பற்றிய சந்மதகங்களுக்கு உரிய முலறயில் விளக்கேளிக்கப்படும். 
தங்கலளப்பற்றிய தகவல்கள் இரகசியோக பாதுகாக்கப்படும். 
இந்த ஆய்வில் இருந்து எப்மபாது மவண்டுோைாலும் தாங்கள் எவ்வித முன்ைறிவிப்பின்றியும், 
எவ்வித சட்டசிக்கலும் இன்றி விைகிக்ககாள்ளைாம். 
இந்த ஆய்வில் பங்மகற்குோறு மகட்டுக்ககாள்கிமறன். 
நன்றி, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ஆய்வாளர் லககயாப்பம்      மநாயாளியின் லககயாப்பம் 
( ேரு.ஹகோ.சுஹரஷ்)     (கபயர்:                 ) 
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குறுக்கத்தின் தைீிரத்ஹதோடு ஒப்பிடும் ஒரு ஆய்வு 
 
ஆய்வாளர்: மரு.ஹகோ.சுஹரஷ்  ( முதுநிலை பட்டமேற்படிப்பு ோணவர், ப ொது 
மருத்துவ பட்டபடிப்பு) 
 
வழிகாட்டி: மரு.க.தமிழ்பெல்வன் (இருதய மருத்துவ துணை மபராசிரியர்) 
அரசு ஸ்டான்ைி ேருத்துவேலை. 
 
சுயஒப்புதல்படிவம் 
 
கபயர்:                                     வயது:                 
உள்ளிருப்பு எண்: 
இந்த ேருத்துவ ஆய்வின் விவரங்கள் எைக்கு விளக்கப்பட்டது. என்னுலடய 
சந்மதகங்கலளக்மகட்கவும், அதற்காை தகுந்த விளக்கங்கலளப் கபறவும் வாய்ப்பளிக்கப்பட்டது. 
நான் இவ்வாய்வில் தன்ைிச்லசயாகத்தான் பங்மகற்கிமறன். எந்த காரணத்திைாலும், எந்த 
கட்டத்திலும், எந்த சட்டசிக்கலும் இன்றி இந்த ஆய்விைிருந்து விைகிக்ககாள்ளைாம் என்றும் 
அறிந்து ககாண்மடன். 
நான் ஆய்விைிருந்து விைகிக்ககாண்டாலும் ஆய்வாளர் என்னுலடய ேருத்துவ அறிக்லககலளப் 
பார்ப்பதற்மகா அல்ைது உபமயாகிக்கமவா என் அனுேதி மதலவயில்லை எைவும் அறிந்து 
ககாண்மடன். என்லைப்பற்றிய தகவல்கள் இரகசியோகப் பாதுகாக்கப்படும் என்பலதயும் 
அறிமவன். 
இந்த ஆய்வின் மூைம் கிலடக்கும் தகவல்கலளயும் பரிமசாதலை முடிவுகலளயும் ஆய்வாளர் 
அவர் விருப்பத்திற்மகற்ப எவ்விதோகப் பயன்படுத்திக்ககாள்ளவும், அதலை பிரசுரிக்கவும் 
முழுேைதுடன் சம்ேதிக்கிமறன். 
இந்த ஆய்வில் பங்குககாள்ள ஒப்புக்ககாள்கிமறன். எைக்கு ககாடுக்கப்பட்ட அறிவுலரகளின்படி 
நடந்து ககாள்வதுடன், ஆய்வாளருக்கு உண்லேயுடன் இருப்மபன் என்றும் உறுதியளிக்கிமறன். 
என் உடல்நைம் பாதிக்கப்பட்டாமைா அல்ைது வழக்கத்திற்கு ோறாை மநாய்க்குறி கதன்பட்டாமைா 
உடமை அலத கதரிவிப்மபன் எை உறுதிகூறுகிமறன். 
இந்த ஆய்வில் எைக்கு எவ்விதோை பரிமசாதலைகலளயும், சிகிச்லசகலளயும் மேற்ககாள்ள 
நான் முழுேைதுடன் சம்ேதிக்கிமறன். 
இப்படிக்கு 
 
 
 
 
 
 
 
 
 
 
 
மநாயொளியின் லககயாப்பம்     ஆய்வாளர் லககயாப்பம்/கபயர் 
 
 (ேருஹகோ.சுஹரஷ்.) 
 (கபயர்:                 ) 
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MASTER CHART 
 
 
 
 
AGE S SMOKING NV HT DM BMI WHR SAD(cm) SAD/TSFT HOMO SBP DBP LDL HDL EF CAG GEN
50 M YES,10 YRS YES NO NO 25 0.989 19.5 6.5 13.50 140 110 95 36 40 SVD 24
49 M NO YES NO NO 24 0.953 21.3 6.65625 1208.00 130 80 90 35 53 DVD 46
48 M YES,20 YRS YES NO NO 26.2 1.0117 22 9.565217 10.56 100 60 120 30 42 TVD 31
43 M YES,40 YRS YES NO NO 24.4418 0.9525 21 5.121951 6.46 130 80 89 39 45 SVD 4
49 M YES,15 YRS YES NO NO 29.01745 0.9533 19.8 5.657143 13.58 120 80 120 32 45 SVD 48
46 M YES,10YRS YES NO NO 23.56 0.957 22 6.470588 7.65 140 90 105 34 42 DVD 92
39 M YES,20YRS YES NO NO 24.53896 0.89 20.2 6.3125 7.52 140 80 110 32 55 NORMAL  
38 F NO YES YES,3YRS YES,6 MON 28.658 0.95 21 4.468085 4.70 110 70 98 42 60 NON OBS CAD 2
48 F NO YES NO NO 26.535 0.91 19.6 5.090909 5.80 120 80 85 45 60 NORMAL 0
49 F NO YES YES,6YRS YES,6YRS 32.89474 1.008 21.2 5.520833 8.40 110 80 105 33 60 SVD 24
47 M NO YES NO YES,3YRS 27.43484 1.21 23 8.214286 29.58 120 90 142 41 33 TVD 68
42 F NO NO NO YES,3YRS 27.89 0.923 21.5 5.972222 9.50 120 80 86 40 62 NORMAL 0
48 F NO YES YES,10YRS NO 27.11111 0.9663 21 6.501548 12.40 150 70 89 50 60 DVD 21
47 F NO YES YES,10YRS YES,5YRS 26.557 0.914 20 4.878049 2.50 150 100 90 40 60 NON OBS CAD 4
42 F NO YES YES,3YRS YES,5YRS 31.62628 0.875 21 5.185185 6.00 120 80 92 37 64 NON OBS CAD 2
39 M yes,3YRS YES YES,1YR YES,1YR 24.856 0.895 19.4 4.974359 5.20 130 80 89 52 60 NON OBS CAD 2.5
48 M NO NO NO NO 22 0.844 21.3 6.016949 5.10 130 80 87 43 50 NON OBS CAD 1
49 M YES,50YRS YES NO NO 26.02617 0.9 22 6.470588 12.50 120 70 99 38 54 DVD 84
46 M YES,20YRS YES NO NO 27.6398 0.985 22.3 6.757576 11.00 120 70 99 45 45 SVD 12
47 M YES,10YRS YES NO NO 20.95717 0.85 19.5 4.875 10.10 110 70 87 42 50 NORMAL 0
47 M NO NO NO NO 23.11111 0.954 22 5.684755 5.32 120 80 95 39 45 SVD 6
45 M YES,30YRS YES NO NO 24.97704 0.923 21 5 4.90 120 80 110 46 45 SVD 24
50 F NO YES NO YES,3YRS 37.195 0.9846 21.1 5.861111 3.58 190 110 104 40 41 SVD 40
38 M NO YES YES,1YR NO 28.13366 0.9762 21.2 6.347305 3.87 100 70 83 46 45 SVD 8
50 M NO YES YES,6MONTHSYE ,18YRS 27.73438 0.9584 21 6.501548 6.50 140 90 88 48 40 SVD 12
48 M YES,10YRS YES NO YES,2YRS 30.40529 0.9623 20.5 5 6.48 140 90 108 50 48 SVD 6
46 M YES,25YRS YES NO YES,10YRS 25.6 1.042 21.2 7.066667 54.20 150 80 91 46 42 TVD 48
45 M NO YES YES,5YRS NO 27.4 1.08 22 6.567164 23.98 120 80 132 43 40 TVD 17
43 M YES,5YRS YES NO NO 19.60716 0.85 20.8 5.621622 6.12 140 80 105 48 40 SVD 10
47 M YES,32YRS YES NO YES,2YRS 26.9 0.9984 22.4 7 35.68 130 80 104 50 48 TVD 22
48 M NO YES YES,5YRS NO 25.46 0.987 21.2 5.888889 4.56 120 60 108 47 62 NORMAL 0
46 F NO NO NO YES,5YRS 25.3 0.88 21.6 5.684211 2.35 136 70 104 43 56 SVD 16
45 F NO YES YES,3YRS YES,4YRS 26.3 0.98 21.6 6.687307 4.89 124 86 85 37 43 SVD 24
42 M yes 20 yrs YES NO NO 24.5 0.96 21.8 6.392962 9.89 130 90 96 34 38 DVD 34
43 F NO YES YES 2YRS YES 5YRS 26.9 1.02 23 7.055215 19.50 120 80 95 34 53 TVD 54
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48 M YES 15 YRS YES NO YES 10YRS 25.6 1.15 23.2 7.182663 28.46 110 70 92 36 42 TVD 58
47 M YES,40 YRS YES YES 6 YRS NO 25.6 0.99 22.1 5.580808 12.90 130 80 95 33 45 SVD 14
49 M YES,15 YRS YES NO NO 29.01745 0.9524 27 6.75 11.26 120 80 120 32 45 SVD 48
50 M YES,10YRS YES NO NO 21.51694 0.924 16 4.571429 12.90 140 90 105 34 42 DVD 92
50 M YES,20YRS YES NO NO 24.53896 0.9535 20 5.405405 4.23 140 80 110 32 55 NORMAL  
45 F NO YES YES,3YRS YES,6 MON 27.84 0.975 21.4 6.114286 4.86 110 70 98 42 60 NON OBS CAD 2
41 F NO YES NO NO 25.453 0.8954 21 6.034483 5.60 120 80 85 45 60 NORMAL 0
62 F NO YES YES,6YRS YES,6YRS 32.89474 1 22.2 6.434783 8.60 110 80 105 33 60 SVD 24
40 M NO YES NO YES,3YRS 27.43484 0.955 22.9 7.02454 25.68 120 90 80 41 33 TVD 68
40 M NO NO YES 5YRS YES,3YRS 28.42 0.9245 21.3 5.916667 2.89 160 90 96 36 35 NORMAL 0
48 F NO YES YES,10YRS NO 27.11111 0.966 21 3.230769 20.42 150 70 89 50 60 DVD 21
46 F NO YES YES,10YRS YES,5YRS 25.6 0.896 21 6.422018 5.46 150 100 90 40 60 NON OBS CAD 4
45 F NO YES YES,3YRS YES,5YRS 22.3 0.9314 21 6.086957 6.87 120 80 92 37 64 NON OBS CAD 2
43 M yes,3YRS YES YES,1YR YES,1YR 21.54 0.96 21.5 5.657895 5.68 126 84 86 45 60 NON OBS CAD 2.5
49 M NO NO NO NO 22 0.844 18 4.5 12.45 130 80 87 43 50 NON OBS CAD 1
47 M YES,50YRS YES NO NO 26.02617 0.9 22 6.790123 26.50 120 70 99 38 54 DVD 84
44 M YES,20YRS YES NO NO 23.4 0.945 21.6 6.315789 6.48 120 70 99 45 45 SVD 12
43 M YES,10YRS YES NO NO 20.95717 0.85 21 6 6.50 110 70 87 42 50 NORMAL 0
49 M NO NO NO NO 23.11111 0.825 21.8 5.589744 5.98 120 80 95 39 45 SVD 6
48 M YES,30YRS YES NO NO 24.97704 0.9125 22.4 6.327684 5.47 120 80 110 46 45 SVD 24
50 F NO YES NO YES,3YRS 37.195 0.967 21 6 8.95 190 110 104 40 41 SVD 38
39 M NO YES YES,1YR NO 23.5 0.945 21.86 6.726154 9.56 100 70 83 46 45 SVD 8
38 M NO YES YES,6MONTHSYE ,18YRS 27.73438 0.9 21.3 6.085714 8.52 140 90 88 48 40 SVD 12
46 M YES,10YRS YES NO YES,2YRS 30.40529 1.047 22.9 5.871795 4.86 140 90 108 50 48 SVD 6
48 M YES,25YRS YES NO YES,12YRS 24.87 0.92 21 5.949008 3.46 146 80 94 47 48 SVD 50
47 M NO YES YES,5YRS NO 25.21736 0.9765 21.8 6.987179 65.45 120 80 87 43 40 TVD 17
49 M YES,5YRS YES NO NO 19.60716 0.879 20.8 5.730028 10.50 140 80 105 48 40 SVD 12
50 M YES,32YRS YES NO YES,2YRS 22.71897 0.984 22.32 7.2 42.53 130 80 104 50 48 TVD 22
50 M NO YES YES,5YRS NO 26.03749 0.947 21.5 5.512821 2.86 120 60 108 47 62 NORMAL 0
46 F NO NO NO YES,5YRS 25.3 0.9756 21.7 5.740741 4.86 136 70 104 43 56 SVD 16
42 F NO YES YES,3YRS YES,4YRS 26.3 0.9845 21.6 5.684211 4.56 124 86 85 37 43 SVD 24
47 M YES,25YRS YES NO YES,10YRS 26.5 0.968 22.8 7.102804 15.98 150 80 91 46 42 TVD 52
47 M NO YES YES,5YRS NO 25.21736 0.9965 24 7.5 38.54 120 80 123 43 40 TVD 17
38 M YES,5YRS YES NO NO 19.60716 0.85 22.1 6.820988 4.85 140 80 105 48 40 SVD 10
53 M YES,32YRS YES NO YES,2YRS 27.3 0.94 22.6 7.040498 45.60 130 80 114 45 48 TVD 22
47 M NO YES YES,5YRS NO 25.988 0.9523 22 5.789474 18.1 120 60 108 47 62 NORMAL 0
53 F NO NO NO YES,5YRS 25.3 0.965 22 6.567164 18.87 136 70 104 43 56 SVD 18
47 F NO YES YES,6YRS NO 24.2 0.9785 21.4 6.858974 13.4 124 86 85 37 43 SVD 26
48 F NO YES NO YES,4.5yRS 22.6 0.9863 21.5 6.697819 23.45 180 74 114 38 43 SVD 42
49 M NO YES YES,6MONTHSYE ,18YRS 22.1 0.9 21 6 8.52 140 90 88 48 40 SVD 12
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KEY TO MASTER CHART 
 
S – SEX 
M – MALE 
F – FEMALE 
NV – NON VEGETARIAN DIET 
HT – HYPERTENSION 
DM – DIABETES 
BMI – BODY MASS INDEX 
SAD – SAGITTAL ABDOMINAL DIAMETER 
TSFT – TRICEPS SKIN FOLD THICKNESS 
WHR – WAIST HIP RATIO 
HOMO – SERUM HOMOCYSTEINE LEVEL 
SBP – SYSTOLIC BLOOD PRESSURE 
DBP – DIASTOLIC BLOOD PRESSURE 
LDL – LOW DENSITY LIPOPROTEIN 
HDL – HIGH DENSITY LIPOPROTEIN 
CAG – CORONARY ANGIOGRAM 
EF – LEFT VENTRICULAR EJECTION FRACTION 
GEN - MODIFIED GENSINI SCORE 
SVD – SINGLE VESSEL DISEASE 
DVD – DOUBLE VESSEL DISEASE 
TVD – TRIBLE VESSEL DISEASE 
NON OBS – NON OBSTRUCTIVE CAD 
UA – UNSTABLE ANGINA 
